<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 21 Aug 2008 15:02:25 BST</pubDate>


	<title>CiteULike: Tag genotype</title>
	<description>CiteULike: Tag genotype</description>


	<link>http://www.citeulike.org/tag/genotype</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/yunyan0201/article/971420"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/xico/article/1402041"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/wilbur/article/232120"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/Thaverkamp/article/2369989"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/stajich/article/2664652"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1394583"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1394584"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/326647"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1433962"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1394589"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2416015"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1535347"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1535342"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2153671"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/411052"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1558865"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2614078"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2614074"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2614069"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2614051"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1535350"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1394587"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/915983"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1394586"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/1218264"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2281075"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2156630"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shupsy/article/2156594"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/shigepong/article/1086640"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/Schmidtc/article/2430828"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/Schmidtc/article/1628218"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/Schmidtc/article/1628216"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/PeterDAdamo/article/771363"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/PeterDAdamo/article/771286"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/PeterDAdamo/article/749641"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/okarsligil/article/525519"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1306019"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1137915"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1300401"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1401455"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1325483"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1240020"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1239993"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/550595"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1273817"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1398887"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1372915"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1300589"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/590787"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/oamg/article/1031951"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/yunyan0201/article/971420">
    <title>Childhood maltreatment, subsequent antisocial behavior, and the role of monoamine oxidase A genotype.</title>
    <link>http://www.citeulike.org/user/yunyan0201/article/971420</link>
    <description>&lt;i&gt;Biol Psychiatry, Vol. 60, No. 7. (1 October 2006), pp. 677-683.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;BACKGROUND: A functional promoter polymorphism in monoamine oxidase A (MAOA) has been implicated as a moderating factor in the relationship between childhood maltreatment and later adolescent and adult antisocial behavior. Despite wide interest in this hypothesis, results remain mixed from the few attempts at replication. METHODS: Regression-based analyses were conducted to test for a genotype-environment interaction using self-reported physical abuse and MAOA genotype to predict later antisocial behavior and arrests for violence by participants in the National Youth Survey Family Study. We also examined the interaction using a measure of violent victimization. The analysis sample included 277 Caucasian male respondents, aged 11-15 in 1976, who provided buccal swab DNA samples and who were successfully genotyped for the variable number tandem repeat (VNTR) in the MAOA promoter using polymerase chain reaction. RESULTS: Maltreatment by a parent during adolescence was a risk factor for adolescent and adult antisocial and violence related behavioral problems. Tests for the main effect of MAOA and a MAOA-maltreatment interaction were nonsignificant. Similar results were obtained using the measure of adolescent violent victimization. CONCLUSIONS: Findings from this general population sample could not confirm the hypothesis that MAOA moderates the relationship between adolescent maltreatment and adolescent or adult antisocial behavior.</description>
    <dc:title>Childhood maltreatment, subsequent antisocial behavior, and the role of monoamine oxidase A genotype.</dc:title>

    <dc:creator>D Huizinga</dc:creator>
    <dc:creator>BC Haberstick</dc:creator>
    <dc:creator>A Smolen</dc:creator>
    <dc:creator>S Menard</dc:creator>
    <dc:creator>SE Young</dc:creator>
    <dc:creator>RP Corley</dc:creator>
    <dc:creator>MC Stallings</dc:creator>
    <dc:creator>J Grotpeter</dc:creator>
    <dc:creator>JK Hewitt</dc:creator>
    <dc:identifier>doi:10.1016/j.biopsych.2005.12.022</dc:identifier>
    <dc:source>Biol Psychiatry, Vol. 60, No. 7. (1 October 2006), pp. 677-683.</dc:source>
    <dc:date>2006-12-02T12:00:07-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>Biol Psychiatry</prism:publicationName>
    <prism:issn>0006-3223</prism:issn>
    <prism:volume>60</prism:volume>
    <prism:number>7</prism:number>
    <prism:startingPage>677</prism:startingPage>
    <prism:endingPage>683</prism:endingPage>
    <prism:category>a</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>monoamine</prism:category>
    <prism:category>oxidase</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/xico/article/1402041">
    <title>Origin of phenotypes: Genes and transcripts.</title>
    <link>http://www.citeulike.org/user/xico/article/1402041</link>
    <description>&lt;i&gt;Genome Res, Vol. 17, No. 6. (June 2007), pp. 682-690.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;While the concept of a gene has been helpful in defining the relationship of a portion of a genome to a phenotype, this traditional term may not be as useful as it once was. Currently, &#34;gene&#34; has come to refer principally to a genomic region producing a polyadenylated mRNA that encodes a protein. However, the recent emergence of a large collection of unannotated transcripts with apparently little protein coding capacity, collectively called transcripts of unknown function (TUFs), has begun to blur the physical boundaries and genomic organization of genic regions with noncoding transcripts often overlapping protein-coding genes on the same (sense) and opposite strand (antisense). Moreover, they are often located in intergenic regions, making the genic portions of the human genome an interleaved network of both annotated polyadenylated and nonpolyadenylated transcripts, including splice variants with novel 5' ends extending hundreds of kilobases. This complex transcriptional organization and other recently observed features of genomes argue for the reconsideration of the term &#34;gene&#34; and suggests that transcripts may be used to define the operational unit of a genome.</description>
    <dc:title>Origin of phenotypes: Genes and transcripts.</dc:title>

    <dc:creator>TR Gingeras</dc:creator>
    <dc:identifier>doi:10.1101/gr.6525007</dc:identifier>
    <dc:source>Genome Res, Vol. 17, No. 6. (June 2007), pp. 682-690.</dc:source>
    <dc:date>2007-06-21T09:01:25-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Genome Res</prism:publicationName>
    <prism:issn>1088-9051</prism:issn>
    <prism:volume>17</prism:volume>
    <prism:number>6</prism:number>
    <prism:startingPage>682</prism:startingPage>
    <prism:endingPage>690</prism:endingPage>
    <prism:category>definition</prism:category>
    <prism:category>gene</prism:category>
    <prism:category>genome</prism:category>
    <prism:category>genome-wide</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>micro-rna</prism:category>
    <prism:category>mrna</prism:category>
    <prism:category>phenotype</prism:category>
    <prism:category>transcript</prism:category>
    <prism:category>transcription</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/wilbur/article/232120">
    <title>Shaping space: The possible and the attainable in RNA genotype-phenotype mapping</title>
    <link>http://www.citeulike.org/user/wilbur/article/232120</link>
    <description>&lt;i&gt;J. Theor. Biol. (1998)&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Understanding which phenotypes are accessible from which genotypes is fundamental for understanding the evolutionary process. This notion of accessibility can be used to define a relation of nearness among phenotypes, independently of their similarity. Because of neutrality, phenotypes denote equivalence classes of genotypes. The definition of neighborhood relations among phenotypes relies, therefore, on the statistics of neighborhood relations among equivalence classes of genotypes in genotype ...</description>
    <dc:title>Shaping space: The possible and the attainable in RNA genotype-phenotype mapping</dc:title>

    <dc:creator>W Fontana</dc:creator>
    <dc:creator>P Schuster</dc:creator>
    <dc:source>J. Theor. Biol. (1998)</dc:source>
    <dc:date>2005-06-19T16:50:10-00:00</dc:date>
    <prism:publicationYear>1998</prism:publicationYear>
    <prism:publicationName>J. Theor. Biol.</prism:publicationName>
    <prism:category>genotype</prism:category>
    <prism:category>phenotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/Thaverkamp/article/2369989">
    <title>Seasonal and habitat-related distribution pattern of Synechococcus genotypes in Lake Constance</title>
    <link>http://www.citeulike.org/user/Thaverkamp/article/2369989</link>
    <description>&lt;i&gt;FEMS Microbiology Ecology, Vol. 62, No. 1. (2007), pp. 64-77.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Abstract The abundance and distribution of Synechococcus spp. in the autotrophic picoplankton of Lake Constance, were followed in the pelagic and littoral habitat by qPCR over 2 years. One genotype, represented by isolated phycoerythrin-rich strain BO 8807, showed a seasonal distribution pattern in both habitats. Before a stable thermal stratification, the maximum of both the Synechococcus population and genotype BO 8807 occurred at 15 or 20 m water depth in the pelagic habitat. During the summer stratification, when the absolute abundance of all Synechococcus spp. was highest above 15 m, the absolute and relative abundance of genotype BO 8807 was maximal at 20 m. These results indicate that Synechococcus spp. or single genotypes are present in deep maxima in Lake Constance. The in situ dynamics of genotype BO 8807 is consistent with the observation that isolated strain BO 8807 requires higher phosphate concentrations for maximum growth rates than a strain from the same phylogenetic cluster that dominates the pelagic summer population. In contrast to these findings, low genome numbers of phycocyanin-rich genotype BO 8805 were found temporarily only in both the littoral and pelagic plankton. Microscopy revealed that PC-rich cells in general occurred preferentially in the littoral habitat. We discuss our results with respect to the versatility of picocyanobacteria of the evolutionary lineage VI of cyanobacteria, and a habitat-related distribution pattern of Synechococcus genotypes.</description>
    <dc:title>Seasonal and habitat-related distribution pattern of Synechococcus genotypes in Lake Constance</dc:title>

    <dc:creator>Sven Becker</dc:creator>
    <dc:creator>Petra Richl</dc:creator>
    <dc:creator>Anneliese Ernst</dc:creator>
    <dc:identifier>doi:10.1111/j.1574-6941.2007.00366.x</dc:identifier>
    <dc:source>FEMS Microbiology Ecology, Vol. 62, No. 1. (2007), pp. 64-77.</dc:source>
    <dc:date>2008-02-13T14:40:24-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>FEMS Microbiology Ecology</prism:publicationName>
    <prism:volume>62</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>64</prism:startingPage>
    <prism:endingPage>77</prism:endingPage>
    <prism:category>cyanobacteria</prism:category>
    <prism:category>diversity</prism:category>
    <prism:category>ecology</prism:category>
    <prism:category>freshwater</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>microbial</prism:category>
    <prism:category>synechococcus</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/stajich/article/2664652">
    <title>The fungus Armillaria bulbosa is among the largest and oldest living organisms</title>
    <link>http://www.citeulike.org/user/stajich/article/2664652</link>
    <description>&lt;i&gt;Nature, Vol. 356, No. 6368. (2 April 1992), pp. 428-431.&lt;/i&gt;</description>
    <dc:title>The fungus Armillaria bulbosa is among the largest and oldest living organisms</dc:title>

    <dc:creator>Myron Smith</dc:creator>
    <dc:creator>Johann Bruhn</dc:creator>
    <dc:creator>James Anderson</dc:creator>
    <dc:identifier>doi:10.1038/356428a0</dc:identifier>
    <dc:source>Nature, Vol. 356, No. 6368. (2 April 1992), pp. 428-431.</dc:source>
    <dc:date>2008-04-13T22:13:31-00:00</dc:date>
    <prism:publicationYear>1992</prism:publicationYear>
    <prism:publicationName>Nature</prism:publicationName>
    <prism:volume>356</prism:volume>
    <prism:number>6368</prism:number>
    <prism:startingPage>428</prism:startingPage>
    <prism:endingPage>431</prism:endingPage>
    <prism:category>armillaria</prism:category>
    <prism:category>fungi</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>largest_organism</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1394583">
    <title>Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments</title>
    <link>http://www.citeulike.org/user/shupsy/article/1394583</link>
    <description>&lt;i&gt;Pharmacological Reviews, Vol. 57, No. 1. (1 March 2005), pp. 1-26.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Opiate and cocaine addictions are major social and medical problems that impose a significant burden on society. Despite the size and scope of these problems, there are few effective treatments for these addictions. Methadone maintenance is an effective and most widely used treatment for opiate addiction, allowing normalization of many physiological abnormalities caused by chronic use of short-acting opiates. There are no pharmacological treatments for cocaine addiction. Epidemiological, linkage, and association studies have demonstrated a significant contribution of genetic factors to the addictive diseases. This article reviews the molecular genetics and pharmacogenetics of opiate and cocaine addictions, focusing primarily on genes of the opioid and monoaminergic systems that have been associated with or have evidence for linkage to opiate or cocaine addiction. This evidence has been marshaled either through identification of variant alleles that lead to functional alterations of gene products, altered gene expression, or findings of linkage or association studies. Studies of polymorphisms in the micro opioid receptor gene, which encodes the receptor target of some endogenous opioids, heroin, morphine, and synthetic opioids, have contributed substantially to knowledge of genetic influences on opiate and cocaine addiction. Other genes of the endogenous opioid and monoaminergic systems, particularly genes encoding dopamine beta-hydroxylase, and the dopamine, serotonin, and norepinephrine transporters have also been implicated. Variants in genes encoding proteins involved in metabolism or biotransformation of drugs of abuse and also of treatment agents are reviewed.</description>
    <dc:title>Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments</dc:title>

    <dc:creator>MJ Kreek</dc:creator>
    <dc:creator>G Bart</dc:creator>
    <dc:creator>C Lilly</dc:creator>
    <dc:creator>KS Laforge</dc:creator>
    <dc:creator>DA Nielsen</dc:creator>
    <dc:identifier>doi:10.1124/pr.57.1.1</dc:identifier>
    <dc:source>Pharmacological Reviews, Vol. 57, No. 1. (1 March 2005), pp. 1-26.</dc:source>
    <dc:date>2007-06-16T18:51:39-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Pharmacological Reviews</prism:publicationName>
    <prism:volume>57</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>1</prism:startingPage>
    <prism:endingPage>26</prism:endingPage>
    <prism:category>cocaine</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>opioids</prism:category>
    <prism:category>pharmacogenetics</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1394584">
    <title>Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction</title>
    <link>http://www.citeulike.org/user/shupsy/article/1394584</link>
    <description>&lt;i&gt;PNAS, Vol. 102, No. 32. (9 August 2005), pp. 11533-11538.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;By using high-density oligonucleotide arrays, we profiled gene expression in reward-related brain regions of rats that developed escalated cocaine intake after extended access to cocaine (6 h per day). Rats allowed restricted daily access to cocaine (only 1 h) that displayed a stable level of cocaine intake and cocaine naive rats were used for controls. Four analysis methods were compared: Affymetrix MICROARRAY SUITE 4 and MICROARRAY SUITE 5, which use perfect-match-minus-mismatch models, and DCHIP and RMA, which use perfect-match-only models to generate expression values. Results were validated by RT-PCR in individual animals from an independent replication of the experiment. A small number of genes was associated with escalated cocaine intake (ESC genes). Unexpectedly, of the brain regions examined [prefrontal cortex, nucleus accumbens, septum, lateral hypothalamus (LH), amygdala, and ventral tegmental area], the LH was the most transcriptionally responsive in escalation of cocaine intake. Most of the ESC genes identified are also expressed during synaptogenesis and synaptic plasticity and include genes that code for several presynaptic and postsynaptic proteins involved in neurotransmission. These results suggest that LH intrinsic circuitry undergoes a structural reorganization during escalation of cocaine use. This remodeling of LH circuitry could contribute to the chronic deficit in reward function that has been hypothesized to drive the transition to drug addiction. Results also support the value of using multiple analysis strategies to identify the most robust changes in gene expression and to compensate for the biases that affect each strategy. 10.1073/pnas.0504438102</description>
    <dc:title>Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction</dc:title>

    <dc:creator>Serge Ahmed</dc:creator>
    <dc:creator>Robert Lutjens</dc:creator>
    <dc:creator>Lena van der Stap</dc:creator>
    <dc:creator>Dusan Lekic</dc:creator>
    <dc:creator>Vincenzo Romano-Spica</dc:creator>
    <dc:creator>Marisela Morales</dc:creator>
    <dc:creator>George Koob</dc:creator>
    <dc:creator>Vez Repunte-Canonigo</dc:creator>
    <dc:creator>Pietro Sanna</dc:creator>
    <dc:identifier>doi:10.1073/pnas.0504438102</dc:identifier>
    <dc:source>PNAS, Vol. 102, No. 32. (9 August 2005), pp. 11533-11538.</dc:source>
    <dc:date>2007-06-16T18:55:53-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>PNAS</prism:publicationName>
    <prism:volume>102</prism:volume>
    <prism:number>32</prism:number>
    <prism:startingPage>11533</prism:startingPage>
    <prism:endingPage>11538</prism:endingPage>
    <prism:category>cocaine</prism:category>
    <prism:category>gene-expression</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>pharmacogenetics</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/326647">
    <title>Genetic Determinants of Addiction to Opioids and Cocaine</title>
    <link>http://www.citeulike.org/user/shupsy/article/326647</link>
    <description>&lt;i&gt;Harvard Review of Psychiatry, Vol. 13, No. 4. (August 2005), pp. 218-232.&lt;/i&gt;</description>
    <dc:title>Genetic Determinants of Addiction to Opioids and Cocaine</dc:title>

    <dc:creator>Andrew Saxon</dc:creator>
    <dc:creator>Michael Oreskovich</dc:creator>
    <dc:creator>Zoran Brkanac</dc:creator>
    <dc:identifier>doi:10.1080/10673220500243364</dc:identifier>
    <dc:source>Harvard Review of Psychiatry, Vol. 13, No. 4. (August 2005), pp. 218-232.</dc:source>
    <dc:date>2005-09-20T03:20:44-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Harvard Review of Psychiatry</prism:publicationName>
    <prism:issn>1067-3229</prism:issn>
    <prism:volume>13</prism:volume>
    <prism:number>4</prism:number>
    <prism:startingPage>218</prism:startingPage>
    <prism:endingPage>232</prism:endingPage>
    <prism:publisher>Taylor and Francis Ltd</prism:publisher>
    <prism:category>cocaine</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>opioids</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1433962">
    <title>Association between Dopamine Transporter (DAT1) Genotype, Left-Sided Inattention, and an Enhanced Response to Methylphenidate in Attention-Deficit Hyperactivity Disorder</title>
    <link>http://www.citeulike.org/user/shupsy/article/1433962</link>
    <description>&lt;i&gt;Neuropsychopharmacology, Vol. 30, No. 12. (2005), pp. 2290-2297.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;A polymorphism of the dopamine transporter gene (DAT1, 10-repeat) is associated with attention-deficit hyperactivity disorder (ADHD) and has been linked to an enhanced response to methylphenidate (MPH). One aspect of the attention deficit in ADHD includes a subtle inattention to left space, resembling that seen after right cerebral hemisphere damage. Since left-sided inattention in ADHD may resolve when treated with MPH, we asked whether left-sided inattention in ADHD was related to DAT1 genotype and the therapeutic efficacy of MPH. A total of 43 ADHD children and their parents were genotyped for the DAT1 3' variable number of tandem repeats polymorphism. The children performed the Landmark Test, a well-validated measure yielding a spatial attentional asymmetry index (leftward to rightward attentional bias). Parents rated their child's response to MPH retrospectively using a three-point scale (no, mediocre or very good response). Additionally, parents used a symptom checklist to rate behavior while on and off medication. A within-family control design determined whether asymmetry indices predicted biased transmission of 10-repeat parental DAT1 alleles and/or response to MPH. It was found that left-sided inattention predicted transmission of the 10-repeat allele from parents to probands and was associated with the severity of ADHD symptomatology. Children rated as achieving a very good response to MPH displayed left-sided inattention, while those rated as achieving a poorer response did not. Our results suggest a subgroup of children with ADHD for whom the 10-repeat DAT1 allele is associated with left-sided inattention. MPH may be most efficacious in this group because it ameliorates a DAT1-mediated hypodopaminergic state.</description>
    <dc:title>Association between Dopamine Transporter (DAT1) Genotype, Left-Sided Inattention, and an Enhanced Response to Methylphenidate in Attention-Deficit Hyperactivity Disorder</dc:title>

    <dc:creator>Mark Bellgrove</dc:creator>
    <dc:creator>Ziarih Hawi</dc:creator>
    <dc:creator>Aiveen Kirley</dc:creator>
    <dc:creator>Michael Fitzgerald</dc:creator>
    <dc:creator>Michael Gill</dc:creator>
    <dc:creator>Ian Robertson</dc:creator>
    <dc:identifier>doi:10.1038/sj.npp.1300839</dc:identifier>
    <dc:source>Neuropsychopharmacology, Vol. 30, No. 12. (2005), pp. 2290-2297.</dc:source>
    <dc:date>2007-07-04T21:59:31-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Neuropsychopharmacology</prism:publicationName>
    <prism:volume>30</prism:volume>
    <prism:number>12</prism:number>
    <prism:startingPage>2290</prism:startingPage>
    <prism:endingPage>2297</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>dat</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>inattention</prism:category>
    <prism:category>methylphenidate</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1394589">
    <title>Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence</title>
    <link>http://www.citeulike.org/user/shupsy/article/1394589</link>
    <description>&lt;i&gt;Psychiatric Genetics, Vol. 15, No. 3. (September 2005), pp. 171-174.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Genetic factors play a role in the vulnerability to cocaine dependence. The reinforcing properties of cocaine are related to the dopaminergic system, and, in particular, the dopamine receptors have been linked to the reward mechanisms. The present study examines the role of the variants TaqI A of the dopamine D2 receptor gene and BalI of the dopamine D3 receptor gene in a Brazilian sample consisting of 730 cocaine dependents and 782 healthy controls. The studied polymorphisms did not show any difference in allelic frequencies or genotypic distribution between the groups. Our data do not support a role for the dopamine D2 receptor gene TaqI A and dopamine D3 receptor gene BalI gene polymorphisms in the susceptibility to cocaine dependence in a Brazilian sample.</description>
    <dc:title>Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence</dc:title>

    <dc:creator>G Messas</dc:creator>
    <dc:creator>I Meira-Lima</dc:creator>
    <dc:creator>M Turchi</dc:creator>
    <dc:creator>O Franco</dc:creator>
    <dc:creator>C Guindalini</dc:creator>
    <dc:creator>A Castelo</dc:creator>
    <dc:creator>R Laranjeira</dc:creator>
    <dc:creator>H Vallada</dc:creator>
    <dc:source>Psychiatric Genetics, Vol. 15, No. 3. (September 2005), pp. 171-174.</dc:source>
    <dc:date>2007-06-16T19:06:45-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Psychiatric Genetics</prism:publicationName>
    <prism:issn>0955-8829</prism:issn>
    <prism:volume>15</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>171</prism:startingPage>
    <prism:endingPage>174</prism:endingPage>
    <prism:category>brazil</prism:category>
    <prism:category>cocaine</prism:category>
    <prism:category>drd2</prism:category>
    <prism:category>drd3</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2416015">
    <title>Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1)</title>
    <link>http://www.citeulike.org/user/shupsy/article/2416015</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 2. (2008), pp. 201-208.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;In this pharmacogenetic study in adults with ADHD (n = 42), a stratified analysis was performed of the association between response to methylphenidate (MPH), assessed under double-blind conditions, and polymorphisms in the genes encoding the dopamine transporter, SLC6A3 (DAT1), the norepinephrine transporter, SLC6A2 (NET), and the dopamine receptor D4, DRD4. The VNTR polymorphism in the 3? untranslated region of SLC6A3 was significantly associated with an increased likelihood of a response to MPH treatment (OR 3.8; 95% CI 1.0-15.2, and OR 5.4; 95% CI 1.4-21.9, depending on the definition of response) in carriers of a single 10-repeat allele compared to patients with the 10/10 genotype. The polymorphisms in DRD4 and the SLC6A2 were not associated with treatment response. This study supports a role of the SLC6A3 genotype in determining the response to MPH in the treatment of adults with ADHD. © 2007 Wiley-Liss, Inc.</description>
    <dc:title>Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1)</dc:title>

    <dc:creator>JS Kooij</dc:creator>
    <dc:creator>AM Boonstra</dc:creator>
    <dc:creator>SH Vermeulen</dc:creator>
    <dc:creator>AG Heister</dc:creator>
    <dc:creator>H Burger</dc:creator>
    <dc:creator>JK Buitelaar</dc:creator>
    <dc:creator>B Franke</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30586</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 2. (2008), pp. 201-208.</dc:source>
    <dc:date>2008-02-22T22:13:26-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</prism:publicationName>
    <prism:volume>147B</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>201</prism:startingPage>
    <prism:endingPage>208</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>adult</prism:category>
    <prism:category>dat</prism:category>
    <prism:category>drd4</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>methylphenidate</prism:category>
    <prism:category>phenotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1535347">
    <title>Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia.</title>
    <link>http://www.citeulike.org/user/shupsy/article/1535347</link>
    <description>&lt;i&gt;Am J Med Genet B Neuropsychiatr Genet, Vol. 136, No. 1. (5 July 2005), pp. 45-52.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Risk for cocaine dependence (CD) is genetically influenced. We recruited a sample of small nuclear families (528 full and 155 half sibpairs) with at least one subject affected with CD. The sample was classified via Bayesian clustering as 45.5% European American (EA) and 54.5% African American (AA). Assessment, via the Semi-Structured Assessment for Drug Dependence and Alcoholism, allowed for detailed evaluation of substance dependence-related traits. To define subgroups with increased genetic homogeneity, consistent with our a priori analytic plan, we used cluster analytic methods to identify six cocaine-related symptom clusters; membership was shown to be significantly heritable. We then completed a genomewide linkage scan (409 markers) for the CD diagnosis, cocaine-induced paranoia (CIP; an outcome that occurs in some cocaine users) and the clusters (three of which contained &#62;80% of the CD subjects). We observed a &#34;suggestive&#34; linkage signal on chromosome 10 for the trait of CD in the full sample; and two &#34;suggestive&#34; linkage signals at different locations on chromosome 3, in the EA part of the sample. We observed a genomewide-significant lod score of 3.65 for the trait of CIP on chromosome 9, in the AA part of the sample only. Our strongest results were observed for the cluster membership traits, including a lod score of 4.66 for membership in the &#34;Heavy Use, Cocaine Predominant&#34; cluster on chromosome 12 (in EAs only) and a lod score of 3.35 for membership in the &#34;Moderate Cocaine and Opioid Abuse&#34; cluster on chromosome 18. These results provide a basis for the identification of specific genes contributing to risk for these traits.</description>
    <dc:title>Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia.</dc:title>

    <dc:creator>J Gelernter</dc:creator>
    <dc:creator>C Panhuysen</dc:creator>
    <dc:creator>R Weiss</dc:creator>
    <dc:creator>K Brady</dc:creator>
    <dc:creator>V Hesselbrock</dc:creator>
    <dc:creator>B Rounsaville</dc:creator>
    <dc:creator>J Poling</dc:creator>
    <dc:creator>M Wilcox</dc:creator>
    <dc:creator>L Farrer</dc:creator>
    <dc:creator>HR Kranzler</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30189</dc:identifier>
    <dc:source>Am J Med Genet B Neuropsychiatr Genet, Vol. 136, No. 1. (5 July 2005), pp. 45-52.</dc:source>
    <dc:date>2007-08-04T18:01:49-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Am J Med Genet B Neuropsychiatr Genet</prism:publicationName>
    <prism:issn>1552-4841</prism:issn>
    <prism:volume>136</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>45</prism:startingPage>
    <prism:endingPage>52</prism:endingPage>
    <prism:category>cip</prism:category>
    <prism:category>cocaine</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>linkage-scan</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1535342">
    <title>Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence.</title>
    <link>http://www.citeulike.org/user/shupsy/article/1535342</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B Neuropsychiatric Genetics, Vol. 139, No. 1. (5 November 2005), pp. 106-108.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The endogenous opioid system has been shown to have a role in the biological processes involved in addiction to numerous drugs of abuse including cocaine. It has recently been reported that the variable nucleotide tandem repeat (VNTR) polymorphism in the 5' promoter region of the prodynorphin gene, which encodes the precursor for three endogenous opioid peptides, is associated with the cocaine dependent phenotype. In order to confirm this finding, we genotyped the prodynorphin promoter polymorphism in cocaine dependent (n = 167) and control (n = 88) individuals of African descent. The results from this experiment indicate a statistically significant (chi2 = 5.64, OR = 1.59, P = 0.018) association between the prodynorphin promoter VNTR polymorphism and the cocaine dependent phenotype. In contrast to previous work showing increased risk conferred by one or two copies of the prodynorphin VNTR, the genotyping results from this study indicate that persons with three or four copies of this polymorphism are more likely to become cocaine dependent. This disparity suggests that the prodynorphin promoter VNTR may not be the functional polymorphism associating with the cocaine dependent phenotype. It is possible that different alleles of the prodynorphin promoter VNTR in the independent populations used for this and the previous study may be in linkage disequilibrium with a yet to be identified functional polymorphism in this gene.</description>
    <dc:title>Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence.</dc:title>

    <dc:creator>JP Dahl</dc:creator>
    <dc:creator>AE Weller</dc:creator>
    <dc:creator>KM Kampman</dc:creator>
    <dc:creator>DW Oslin</dc:creator>
    <dc:creator>FW Lohoff</dc:creator>
    <dc:creator>TN Ferraro</dc:creator>
    <dc:creator>CP O'Brien</dc:creator>
    <dc:creator>WH Berrettini</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30238</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B Neuropsychiatric Genetics, Vol. 139, No. 1. (5 November 2005), pp. 106-108.</dc:source>
    <dc:date>2007-08-04T17:56:48-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B Neuropsychiatric Genetics</prism:publicationName>
    <prism:issn>1552-4841</prism:issn>
    <prism:volume>139</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>106</prism:startingPage>
    <prism:endingPage>108</prism:endingPage>
    <prism:category>african-americans</prism:category>
    <prism:category>cocaine</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>prodynorphin</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2153671">
    <title>Gene Expression in Human Hippocampus from Cocaine Abusers Identifies Genes which Regulate Extracellular Matrix Remodeling.</title>
    <link>http://www.citeulike.org/user/shupsy/article/2153671</link>
    <description>&lt;i&gt;PLoS ONE, Vol. 2, No. 11. (2007)&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The chronic effects of cocaine abuse on brain structure and function are blamed for the inability of most addicts to remain abstinent. Part of the difficulty in preventing relapse is the persisting memory of the intense euphoria or cocaine &#34;rush&#34;. Most abused drugs and alcohol induce neuroplastic changes in brain pathways subserving emotion and cognition. Such changes may account for the consolidation and structural reconfiguration of synaptic connections with exposure to cocaine. Adaptive hippocampal plasticity could be related to specific patterns of gene expression with chronic cocaine abuse. Here, we compare gene expression profiles in the human hippocampus from cocaine addicts and age-matched drug-free control subjects. Cocaine abusers had 151 gene transcripts upregulated, while 91 gene transcripts were downregulated. Topping the list of cocaine-regulated transcripts was RECK in the human hippocampus (FC = 2.0; p&#60;0.05). RECK is a membrane-anchored MMP inhibitor that is implicated in the coordinated regulation of extracellular matrix integrity and angiogenesis. In keeping with elevated RECK expression, active MMP9 protein levels were decreased in the hippocampus from cocaine abusers. Pathway analysis identified other genes regulated by cocaine that code for proteins involved in the remodeling of the cytomatrix and synaptic connections and the inhibition of blood vessel proliferation (PCDH8, LAMB1, ITGB6, CTGF and EphB4). The observed microarray phenotype in the human hippocampus identified RECK and other region-specific genes that may promote long-lasting structural changes with repeated cocaine abuse. Extracellular matrix remodeling in the hippocampus may be a persisting effect of chronic abuse that contributes to the compulsive and relapsing nature of cocaine addiction.</description>
    <dc:title>Gene Expression in Human Hippocampus from Cocaine Abusers Identifies Genes which Regulate Extracellular Matrix Remodeling.</dc:title>

    <dc:creator>DC Mash</dc:creator>
    <dc:creator>J Ffrench-Mullen</dc:creator>
    <dc:creator>N Adi</dc:creator>
    <dc:creator>Y Qin</dc:creator>
    <dc:creator>A Buck</dc:creator>
    <dc:creator>J Pablo</dc:creator>
    <dc:identifier>doi:10.1371/journal.pone.0001187</dc:identifier>
    <dc:source>PLoS ONE, Vol. 2, No. 11. (2007)</dc:source>
    <dc:date>2007-12-21T02:43:00-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>PLoS ONE</prism:publicationName>
    <prism:issn>1932-6203</prism:issn>
    <prism:volume>2</prism:volume>
    <prism:number>11</prism:number>
    <prism:category>cocaine</prism:category>
    <prism:category>gene-expression</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>hippocampus</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/411052">
    <title>(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population</title>
    <link>http://www.citeulike.org/user/shupsy/article/411052</link>
    <description>&lt;i&gt;The Pharmacogenomics Journal, Vol. aop, No. current.&lt;/i&gt;</description>
    <dc:title>(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population</dc:title>

    <dc:creator>N Ballon</dc:creator>
    <dc:creator>S Leroy</dc:creator>
    <dc:creator>C Roy</dc:creator>
    <dc:creator>MC Bourdel</dc:creator>
    <dc:creator>A Charles-Nicolas</dc:creator>
    <dc:creator>MO Krebs</dc:creator>
    <dc:creator>MF Poirier</dc:creator>
    <dc:creator></dc:creator>
    <dc:identifier>doi:10.1038/sj.tpj.6500352</dc:identifier>
    <dc:source>The Pharmacogenomics Journal, Vol. aop, No. current.</dc:source>
    <dc:date>2005-11-29T07:58:23-00:00</dc:date>
    <prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
    <prism:issn>1470-269X</prism:issn>
    <prism:volume>aop</prism:volume>
    <prism:number>current</prism:number>
    <prism:publisher>Nature Publishing Group</prism:publisher>
    <prism:category>african-caribbeans</prism:category>
    <prism:category>cannabinoid-receptor</prism:category>
    <prism:category>cnr1</prism:category>
    <prism:category>cocaine</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1558865">
    <title>Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse.</title>
    <link>http://www.citeulike.org/user/shupsy/article/1558865</link>
    <description>&lt;i&gt;Am J Med Genet, Vol. 114, No. 4. (8 May 2002), pp. 429-435.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;It has been demonstrated that the opioid peptide dynorphin plays a role in modulating responses to several psychoactive substances including cocaine. Our laboratory and others have found that mRNA levels of dynorphin in the caudate and putamen are elevated after acute or chronic cocaine exposure in rats. Recently, a 68-base pair (bp) repeat polymorphism within the core promoter region of the human prodynorphin gene has been reported to occur in alleles containing one, two, three, or four copies. This repeat contains a putative AP-1 transcription factor binding site; reporter gene constructs with three or four, but not one or two, copies of the tandem repeats were shown to be associated with increases in transcriptional activation in in vitro cellular assays. We hypothesize that this polymorphism may be associated with individual differences in vulnerability to cocaine dependence or abuse. From an ongoing study of the genetics of addiction, 174 subjects were studied, including individuals with a primary diagnosis (DSM-IV criteria) of cocaine dependence (N = 61) or abuse (N = 22), and controls with no history of any substance dependence or abuse (N = 91). We designed primers for polymerase chain reaction (PCR) to amplify sequences of the promoter region of the prodynorphin gene containing the repeat element. The association of alleles containing three or four repeats with cocaine dependence/abuse was examined. With data stratified by ethnic group, pooled relative risk (RR) with Mantel-Haenszel Chi square was calculated: RR = 0.59 (95% confidence interval 0.37-0.95), chi2 (1) = 4.14, P = 0.042. Our results suggest that this allelic variation at the promoter region of the prodynorphin gene (alleles with three or four repeats), which may result in enhanced transcription of the gene, may contribute to relative protection and decrease individual vulnerability to develop cocaine dependence or abuse.</description>
    <dc:title>Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse.</dc:title>

    <dc:creator>AC Chen</dc:creator>
    <dc:creator>KS LaForge</dc:creator>
    <dc:creator>A Ho</dc:creator>
    <dc:creator>PF McHugh</dc:creator>
    <dc:creator>S Kellogg</dc:creator>
    <dc:creator>K Bell</dc:creator>
    <dc:creator>RP Schluger</dc:creator>
    <dc:creator>SM Leal</dc:creator>
    <dc:creator>MJ Kreek</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.10362</dc:identifier>
    <dc:source>Am J Med Genet, Vol. 114, No. 4. (8 May 2002), pp. 429-435.</dc:source>
    <dc:date>2007-08-13T21:03:48-00:00</dc:date>
    <prism:publicationYear>2002</prism:publicationYear>
    <prism:publicationName>Am J Med Genet</prism:publicationName>
    <prism:issn>0148-7299</prism:issn>
    <prism:volume>114</prism:volume>
    <prism:number>4</prism:number>
    <prism:startingPage>429</prism:startingPage>
    <prism:endingPage>435</prism:endingPage>
    <prism:category>cocaine</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>prodynorphin</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2614078">
    <title>An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD</title>
    <link>http://www.citeulike.org/user/shupsy/article/2614078</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 397-402.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Since neurocognitive performance is a possible endophenotype for Attention Deficit Hyperactivity Disorder (ADHD) we explored the relationship between four genetic polymorphisms and neurocognitive performance in adults with ADHD. We genotyped a sample of 45 adults with ADHD at four candidate polymorphisms for the disorder (DRD4 48 base pair (bp) repeat, DRD4 120 bp duplicated repeat, SLC6A3 (DAT1) 40 bp variable number of tandem repeats (VNTR), and COMT Val158Met). We then sub-grouped the sample for each polymorphism by genotype or by the presence of the (putative) ADHD risk allele and compared the performance of the subgroups on a large battery of neurocognitive tests. The COMT Val158Met polymorphism was related to differences in IQ and reaction time, both of the DRD4 polymorphisms (48 bp repeat and 120 bp duplication) showed an association with verbal memory skills, and the SLC6A3 40 bp VNTR polymorphism could be linked to differences in inhibition. Interestingly, the presence of the risk alleles in DRD4 and SLC6A3 was related to better cognitive performance. Our findings contribute to an improved understanding of the functional implications of risk genes for ADHD</description>
    <dc:title>An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD</dc:title>

    <dc:creator>AM Boonstra</dc:creator>
    <dc:creator>JJS Kooij</dc:creator>
    <dc:creator>JK Buitelaar</dc:creator>
    <dc:creator>J Oosterlaan</dc:creator>
    <dc:creator>JA Sergeant</dc:creator>
    <dc:creator>Heister</dc:creator>
    <dc:creator>B Franke</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30595</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 397-402.</dc:source>
    <dc:date>2008-03-30T22:56:19-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</prism:publicationName>
    <prism:volume>147B</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>397</prism:startingPage>
    <prism:endingPage>402</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>adult</prism:category>
    <prism:category>comt</prism:category>
    <prism:category>dat</prism:category>
    <prism:category>drd4</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>neurocognitive-testing</prism:category>
    <prism:category>neuropsychology</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2614074">
    <title>The monoamine oxidase B gene exhibits significant association to ADHD</title>
    <link>http://www.citeulike.org/user/shupsy/article/2614074</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 370-374.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Attention deficit hyperactivity disorder (ADHD) is a common neuropsychiatric condition with strong genetic basis. Recent work in China indicated that ADHD may be linked to Xp1-2 in the Han Chinese population. The gene encoding monoamine oxidase B (MAOB), the main enzyme degrading dopamine in the human brain, is located in this region. The current study sequenced the exons and the 5' and 3' flanking regions of the MAOB gene and found four common variants including 2276C&#62;T and 2327C&#62;T in exon 15, rs1799836 in intron 13 and rs1040399 in 3'-UTR. We assessed the association of these variants with ADHD in 548 trios collected from 468 males and 80 females probands. TDT analysis showed that alleles of each polymorphism were preferentially transmitted to probands (rs1799836, P=3.28E-15; rs1040399, P=1.87E-6; 2276T&#62;C or 2327T&#62;C, P=2.20E-6) and haplotype-based TDT analyses also found distorted transmission. In conclusion, this study provides the strongest evidence for the involvement of MAOB gene in the etiology of ADHD to date, at least in Han Chinese population</description>
    <dc:title>The monoamine oxidase B gene exhibits significant association to ADHD</dc:title>

    <dc:creator>J Li</dc:creator>
    <dc:creator>Y Wang</dc:creator>
    <dc:creator>S Hu</dc:creator>
    <dc:creator>R Zhou</dc:creator>
    <dc:creator>X Yu</dc:creator>
    <dc:creator>B Wang</dc:creator>
    <dc:creator>L Guan</dc:creator>
    <dc:creator>L Yang</dc:creator>
    <dc:creator>F Zhang</dc:creator>
    <dc:creator>SV Faraone</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30606</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 370-374.</dc:source>
    <dc:date>2008-03-30T22:49:51-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</prism:publicationName>
    <prism:volume>147B</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>370</prism:startingPage>
    <prism:endingPage>374</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>familial-study</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>mao-b</prism:category>
    <prism:category>phenotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2614069">
    <title>No evidence for genetic association between DARPP-32 (PP1R1B) polymorphisms and attention deficit hyperactivity disorder</title>
    <link>http://www.citeulike.org/user/shupsy/article/2614069</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 339-342.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Attention deficit hyperactivity disorder (ADHD) has a strong genetic basis, and evidence from human and animal studies suggests that a dopamine system dysfunction plays a role in the disorder pathophysiology. Several genes involved in dopamine neurotransmission have shown replicated genetic association with ADHD. These include the dopamine receptors D4 (DRD4), D5 (DRD5), and the dopamine transporter (DAT1) genes. Recently, evidence has also accumulated in favor of the dopamine receptor D1 gene (DRD1). The dopamine- and cAMP-regulated phosphoprotein of relative molecular mass of 32 kDa (DARPP-32) is a key component of dopamine signaling, acting as a converging point for several neurotransmitter systems influencing dopaminergic neurons and regulating a wide variety of downstream effectors. Here, we tested the DARPP-32 gene, PPP1R1B, for association with ADHD using four polymorphic markers selected across the gene in a sample of 255 ADHD families. We did not detect evidence of association of individual marker alleles and haplotype analysis did not reveal significant association in this sample of families. Moreover, we found no relationship between the same alleles or haplotypes and symptom scores of inattention or hyperactivity/impulsivity in these families using a quantitative approach. In conclusion, albeit a key regulatory role in dopamine signaling, our data do not support a major contribution of the DARPP-32 gene in ADHD</description>
    <dc:title>No evidence for genetic association between DARPP-32 (PP1R1B) polymorphisms and attention deficit hyperactivity disorder</dc:title>

    <dc:creator>N Laurin</dc:creator>
    <dc:creator>A Ickowicz</dc:creator>
    <dc:creator>T Pathare</dc:creator>
    <dc:creator>M Malone</dc:creator>
    <dc:creator>R Tannock</dc:creator>
    <dc:creator>R Schachar</dc:creator>
    <dc:creator>JL Kennedy</dc:creator>
    <dc:creator>CL Barr</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30604</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 339-342.</dc:source>
    <dc:date>2008-03-30T22:45:43-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</prism:publicationName>
    <prism:volume>147B</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>339</prism:startingPage>
    <prism:endingPage>342</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>darpp-32</prism:category>
    <prism:category>dopamine-signaling</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>phenotype</prism:category>
    <prism:category>polymorphism</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2614051">
    <title>Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder</title>
    <link>http://www.citeulike.org/user/shupsy/article/2614051</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 316-319.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;A major goal of genetic studies of attention deficit hyperactivity disorder (ADHD) is to identify individual characteristics that might help segregate the disorder's inherent heterogeneity. [Mill et al. (2006); Arch Ger Psychiatry 63:462-469] recently reported a potentially important association between two dopamine-related risk polymorphisms (DRD4 variable number tandem repeat (VNTR) in exon 3 and DAT1 VNTR in the 3 UTR) and lowered IQ in ADHD. The objective of the current study was to replicate the [Mill et al. (2006); Arch Ger Psychiatry 63:462-469] findings in a clinical sample and to extend the analysis to a large range of alternative SNP markers of putative ADHD risk alleles identified in a recent study [Brookes et al. (2006); Mol Genet 11:934-953]. Participants were 1081 children and adolescents with a research-confirmed combined type ADHD diagnosis and 1300 unaffected siblings who took part in the International Multi-centre ADHD Genetics (IMAGE) project. They were recruited from multiple settings from across Europe: Belgium, Britain, Germany, Ireland, Israel, Netherlands, Spain and Switzerland. The results were that ADHD was associated with reduced IQ. However, there was no association between the two dopamine-related risk polymorphisms and IQ in either the probands or their siblings. Furthermore, other selected genetic markers previously demonstrated to be associated with ADHD in this sample were not associated with IQ. This large scale study with a clinically ascertained and regorously diagnosed sample failed to replicate the association between genetic polymorphisms in the dopamine system and IQ in ADHD. We also observed no association of other SNPs with IQ in ADHD</description>
    <dc:title>Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder</dc:title>

    <dc:creator>EJS Sonuga-Barke</dc:creator>
    <dc:creator>KJ Brookes</dc:creator>
    <dc:creator>J Buitelaar</dc:creator>
    <dc:creator>R Anney</dc:creator>
    <dc:creator>P Bitsakou</dc:creator>
    <dc:creator>D Baeyens</dc:creator>
    <dc:creator>C Buschgens</dc:creator>
    <dc:creator>W Chen</dc:creator>
    <dc:creator>H Christiansen</dc:creator>
    <dc:creator>J Eisenberg</dc:creator>
    <dc:creator>J Kuntsi</dc:creator>
    <dc:creator>I Manor</dc:creator>
    <dc:creator>A Meliá</dc:creator>
    <dc:creator>A Mulligan</dc:creator>
    <dc:creator>N Rommelse</dc:creator>
    <dc:creator>UC Müller</dc:creator>
    <dc:creator>H Uebel</dc:creator>
    <dc:creator>T Banaschewski</dc:creator>
    <dc:creator>R Ebstein</dc:creator>
    <dc:creator>B Franke</dc:creator>
    <dc:creator>M Gill</dc:creator>
    <dc:creator>A Miranda</dc:creator>
    <dc:creator>RD Oades</dc:creator>
    <dc:creator>H Roeyers</dc:creator>
    <dc:creator>A Rothenberger</dc:creator>
    <dc:creator>J Sergeant</dc:creator>
    <dc:creator>HC Steinhausen</dc:creator>
    <dc:creator>M Thompson</dc:creator>
    <dc:creator>E Taylor</dc:creator>
    <dc:creator>P Asherson</dc:creator>
    <dc:creator>SV Faraone</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30596</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 3. (March 2008), pp. 316-319.</dc:source>
    <dc:date>2008-03-30T22:29:46-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</prism:publicationName>
    <prism:volume>147B</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>316</prism:startingPage>
    <prism:endingPage>319</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>adolescent</prism:category>
    <prism:category>child</prism:category>
    <prism:category>dat</prism:category>
    <prism:category>drd4</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>intelligence</prism:category>
    <prism:category>phenotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1535350">
    <title>CNR1 Variation Modulates Risk for Drug and Alcohol Dependence</title>
    <link>http://www.citeulike.org/user/shupsy/article/1535350</link>
    <description>&lt;i&gt;Biological Psychiatry, Vol. 62, No. 6. (15 September 2007), pp. 616-626.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Background Human cannabinoid receptor 1 (CB1), which is encoded by the CNR1 gene, may play a role in the development of substance dependence (SD). Following initial reports of association of CNR1 with SD, we studied multiple markers at this locus in a large case-control sample.Methods Ten CNR1 markers and 38 ancestry-informative markers were genotyped in 451 healthy control subjects and 550 SD (AD and/or DD) patients (including European Americans [EAs] and African Americans [AAs]). Common confounding effects on association analysis of population stratification and admixture, age, and sex were controlled for using regression analysis. Disease risk and protective alleles were fine-mapped using a linkage disequilibrium measure ([delta]).Results In EAs, risk for each SD subtype significantly increased with the number of &#34;G&#34; alleles at rs6454674 (single nucleotide polymorphisms [SNP]3). SNP3^G+ (the genotypes containing a G allele) and SNP8^T/T genotypes had significant interaction effects (p = .0003 for comorbid DD and AD, .0002 for DD, and .007 for AD). SNP3 and SNP8 together exerted stronger genetic effects on SD than either did individually. The peak [delta] values among all the markers were seen for SNP3 and SNP8 (rs806368).Conclusions We demonstrate that CNR1 variation and interactive effects play important roles in risk for both DD and AD.</description>
    <dc:title>CNR1 Variation Modulates Risk for Drug and Alcohol Dependence</dc:title>

    <dc:creator>Lingjun Zuo</dc:creator>
    <dc:creator>Henry Kranzler</dc:creator>
    <dc:creator>Xingguang Luo</dc:creator>
    <dc:creator>Jonathan Covault</dc:creator>
    <dc:creator>Joel Gelernter</dc:creator>
    <dc:identifier>doi:10.1016/j.biopsych.2006.12.004</dc:identifier>
    <dc:source>Biological Psychiatry, Vol. 62, No. 6. (15 September 2007), pp. 616-626.</dc:source>
    <dc:date>2007-08-04T18:06:31-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Biological Psychiatry</prism:publicationName>
    <prism:volume>62</prism:volume>
    <prism:number>6</prism:number>
    <prism:startingPage>616</prism:startingPage>
    <prism:endingPage>626</prism:endingPage>
    <prism:category>alcohol</prism:category>
    <prism:category>cnr1</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>psychiatric-genetics</prism:category>
    <prism:category>sud</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1394587">
    <title>A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.</title>
    <link>http://www.citeulike.org/user/shupsy/article/1394587</link>
    <description>&lt;i&gt;Proc Natl Acad Sci U S A, Vol. 103, No. 12. (21 March 2006), pp. 4552-4557.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The dopamine (DA) transporter DAT1 is a major target bound by cocaine in brain. We examined the influence of functional genetic variants in DAT1 on cocaine addiction. Repeat polymorphisms, including a 30-bp variable-number tandem repeat (VNTR) in intron 8 (Int8 VNTR) with two common alleles, were genotyped in cocaine-dependent abusers (n = 699) and in controls with no past history of drug abuse (n = 866) from São Paulo, Brazil. Positive association was observed with allele 3 of the Int8 VNTR and cocaine abuse (allele odds ratio = 1.2, 95% confidence interval = 1.01-1.37, P = 0.036; 3/3 homozygote odds ratio = 1.45, 95% confidence interval = 1.18-1.78, P = 0.0008). Population stratification was assessed and did not affect the results. Haplotypic analyses using additional polymorphisms indicated that the Int8 VNTR is responsible for the observed association. Functional analyses in reporter-gene constructs, demonstrated that allele 3 mediates significant (P &#60; 0.05) but small reduced expression compared with the &#34;protective&#34; allele 2. This difference increased when 1 and 10 muM cocaine was added to the cell culture ( approximately 40% reduction of the 3 allele expression versus the 2 allele). The 3 allele also demonstrated approximately 3-fold-increased expression over the 2 allele in response to KCl plus forskolin challenge. We demonstrate a robust association between cocaine dependence and a VNTR allele in SLC6A3, conferring a small but detectable effect, and we show that this VNTR may be functional. This study suggests that DAT1 gene variation may play a role in cocaine dependence etiology.</description>
    <dc:title>A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.</dc:title>

    <dc:creator>C Guindalini</dc:creator>
    <dc:creator>M Howard</dc:creator>
    <dc:creator>K Haddley</dc:creator>
    <dc:creator>R Laranjeira</dc:creator>
    <dc:creator>D Collier</dc:creator>
    <dc:creator>N Ammar</dc:creator>
    <dc:creator>I Craig</dc:creator>
    <dc:creator>C O'Gara</dc:creator>
    <dc:creator>VJ Bubb</dc:creator>
    <dc:creator>T Greenwood</dc:creator>
    <dc:creator>J Kelsoe</dc:creator>
    <dc:creator>P Asherson</dc:creator>
    <dc:creator>RM Murray</dc:creator>
    <dc:creator>A Castelo</dc:creator>
    <dc:creator>JP Quinn</dc:creator>
    <dc:creator>H Vallada</dc:creator>
    <dc:creator>G Breen</dc:creator>
    <dc:identifier>doi:10.1073/pnas.0504789103</dc:identifier>
    <dc:source>Proc Natl Acad Sci U S A, Vol. 103, No. 12. (21 March 2006), pp. 4552-4557.</dc:source>
    <dc:date>2007-06-16T19:01:37-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>Proc Natl Acad Sci U S A</prism:publicationName>
    <prism:issn>0027-8424</prism:issn>
    <prism:volume>103</prism:volume>
    <prism:number>12</prism:number>
    <prism:startingPage>4552</prism:startingPage>
    <prism:endingPage>4557</prism:endingPage>
    <prism:category>brazil</prism:category>
    <prism:category>cocaine</prism:category>
    <prism:category>dat</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/915983">
    <title>Neuroscience of Addiction</title>
    <link>http://www.citeulike.org/user/shupsy/article/915983</link>
    <description>&lt;i&gt;Neuron, Vol. 21, No. 3. (September 1998), pp. 467-476.&lt;/i&gt;</description>
    <dc:title>Neuroscience of Addiction</dc:title>

    <dc:creator>George Koob</dc:creator>
    <dc:creator>Pietro Sanna</dc:creator>
    <dc:creator>Floyd Bloom</dc:creator>
    <dc:identifier>doi:10.1016/S0896-6273(00)80557-7</dc:identifier>
    <dc:source>Neuron, Vol. 21, No. 3. (September 1998), pp. 467-476.</dc:source>
    <dc:date>2006-10-29T01:41:29-00:00</dc:date>
    <prism:publicationYear>1998</prism:publicationYear>
    <prism:publicationName>Neuron</prism:publicationName>
    <prism:volume>21</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>467</prism:startingPage>
    <prism:endingPage>476</prism:endingPage>
    <prism:category>cocaine</prism:category>
    <prism:category>ethanol</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>nicotine</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1394586">
    <title>A GSTP1 functional variant associated with cocaine dependence in a Brazilian population.</title>
    <link>http://www.citeulike.org/user/shupsy/article/1394586</link>
    <description>&lt;i&gt;Pharmacogenet Genomics, Vol. 15, No. 12. (December 2005), pp. 891-893.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Cocaine dependence aetiology is complex and genetically influenced. We hypothesize that, for many users, efficient metabolism of cocaine and its toxic byproducts aids persistent cocaine use, such as that leading to dependence. The glutathione-S-transferases - in particular, GST-Pi - may be important in preventing cocaine and alcohol-induced oxidative damage. We genotyped a GST-Pi functional polymorphism (Ile105Val) in 654 male cocaine users and 572 controls from Brazil. Genotype and allele frequencies of Ile105Val differed significantly (chi = 6.74; P=0.03 and chi = 6.54; P = 0.01, respectively). Ile/Ile cocaine dependents had an OR = 1.31 (95%CI: 1.04-1.65), and Ile/Ile dependents consuming &#62;50 units alcohol weekly an OR of 1.44 (95% CI:1.06-1.96). Population stratification was assessed and did not affect the results. These data require replication but do suggest that the high activity Ile105 GST-Pi allele may influence the aetiology and development of cocaine dependence.</description>
    <dc:title>A GSTP1 functional variant associated with cocaine dependence in a Brazilian population.</dc:title>

    <dc:creator>C Guindalini</dc:creator>
    <dc:creator>C O'Gara</dc:creator>
    <dc:creator>R Laranjeira</dc:creator>
    <dc:creator>D Collier</dc:creator>
    <dc:creator>A Castelo</dc:creator>
    <dc:creator>H Vallada</dc:creator>
    <dc:creator>G Breen</dc:creator>
    <dc:source>Pharmacogenet Genomics, Vol. 15, No. 12. (December 2005), pp. 891-893.</dc:source>
    <dc:date>2007-06-16T19:00:26-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Pharmacogenet Genomics</prism:publicationName>
    <prism:issn>1744-6872</prism:issn>
    <prism:volume>15</prism:volume>
    <prism:number>12</prism:number>
    <prism:startingPage>891</prism:startingPage>
    <prism:endingPage>893</prism:endingPage>
    <prism:category>brazil</prism:category>
    <prism:category>cocaine</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>glutathione-s-transferases</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/1218264">
    <title>The genetics of gambling and behavioral addictions.</title>
    <link>http://www.citeulike.org/user/shupsy/article/1218264</link>
    <description>&lt;i&gt;CNS Spectrums, Vol. 11, No. 12. (December 2006), pp. 931-939.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Behavioral addictions are considered as the repetitive occurrence of impulsive behaviors without consideration of their potential negative consequences. These addictions represent an increasing cost to society and are an important new field of research in psychiatric genetics. There has been a growing body of evidence on the familial aggregation and genetic influences on the development of behavioral addictions and mainly on pathological gambling. The aim of this article is to critically review findings of family and molecular genetic studies on behavioral addictions, focusing on pathological gambling and commenting on other disorders where appropriate. This review provides a comprehensive approach to genetic studies on behavioral addiction and points out the necessity of expanding the genetic research in this field. Future directions for genetic studies in this field are also discussed.</description>
    <dc:title>The genetics of gambling and behavioral addictions.</dc:title>

    <dc:creator>DS Lobo</dc:creator>
    <dc:creator>JL Kennedy</dc:creator>
    <dc:source>CNS Spectrums, Vol. 11, No. 12. (December 2006), pp. 931-939.</dc:source>
    <dc:date>2007-04-09T20:40:27-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>CNS Spectrums</prism:publicationName>
    <prism:issn>1092-8529</prism:issn>
    <prism:volume>11</prism:volume>
    <prism:number>12</prism:number>
    <prism:startingPage>931</prism:startingPage>
    <prism:endingPage>939</prism:endingPage>
    <prism:category>decision-making</prism:category>
    <prism:category>gambling</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2281075">
    <title>GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence</title>
    <link>http://www.citeulike.org/user/shupsy/article/2281075</link>
    <description>&lt;i&gt;Journal of Psychiatric Research, Vol. 42, No. 3. (February 2008), pp. 184-191.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Gamma-aminobutyric acid (GABA) A receptors are believed to mediate some of the physiological and behavioral actions of ethanol. Recent studies have suggested that genetic variants of the GABA-A receptor alpha2 subunit gene (GABRA2) are associated with alcohol dependence. The aim of this study is to confirm and extend the role of GABRA2 haplotypes in the liability to alcohol dependence. 291 (231 male) treatment-seeking alcohol-dependent individuals and 295 (153 male) control subjects were enrolled into the study. Characteristics of alcohol dependence were obtained using the SSAGA (semi-structured assessment of the genetics of alcoholism, German Version). Genotyping of 10 SNPs across the GABRA2 gene was performed following previous reports and using PCR. One genetic variant was detected to significantly differ between alcohol-dependent subjects and controls. Two common 8 SNP haplotypes and their complementary alleles were identified containing this SNP and were present in 89.9% of controls and 93.4% of the alcohol-dependent individuals. One of the haplotypes (T-C-A-C-A-T-T-C) was significantly associated with alcohol dependence and characteristics of alcohol withdrawal and severity of alcohol dependence (delirium tremens, withdrawal seizures). These findings support and extend the three previous studies implicating a GABA-A receptor subunit as contributing to the genetic risk for alcohol dependence. Possible implications of these findings are discussed.</description>
    <dc:title>GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence</dc:title>

    <dc:creator>M Soyka</dc:creator>
    <dc:creator>UW Preuss</dc:creator>
    <dc:creator>V Hesselbrock</dc:creator>
    <dc:creator>P Zill</dc:creator>
    <dc:creator>G Koller</dc:creator>
    <dc:creator>B Bondy</dc:creator>
    <dc:identifier>doi:10.1016/j.jpsychires.2006.11.006</dc:identifier>
    <dc:source>Journal of Psychiatric Research, Vol. 42, No. 3. (February 2008), pp. 184-191.</dc:source>
    <dc:date>2008-01-23T16:10:29-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>Journal of Psychiatric Research</prism:publicationName>
    <prism:volume>42</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>184</prism:startingPage>
    <prism:endingPage>191</prism:endingPage>
    <prism:category>alcohol</prism:category>
    <prism:category>gaba</prism:category>
    <prism:category>gene-expression</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2156630">
    <title>Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth</title>
    <link>http://www.citeulike.org/user/shupsy/article/2156630</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 1. (2008), pp. 94-99.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Season of birth (SOB) has been associated with attention deficit hyperactivity disorder (ADHD) in two existing studies. One further study reported an interaction between SOB and genotypes of the dopamine D4 receptor (DRD4) gene. It is important that these findings are further investigated to confirm or refute the findings. In this study, we investigated the SOB association with ADHD in four independent samples collected for molecular genetic studies of ADHD and found a small but significant increase in summer births compared to a large population control dataset. We also observed a significant association with the 7-repeat allele of the DRD4 gene variable number tandem repeat polymorphism in exon three with probands born in the winter season, with no significant differential transmission of this allele between summer and winter seasons. Preferential transmission of the 2-repeat allele to ADHD probands occurred in those who were born during the summer season, but did not surpass significance for association, even though the difference in transmission between the two seasons was nominally significant. However, following adjustment for multiple testing of alleles none of the SOB effects remained significant. We conclude that the DRD4 7-repeat allele is associated with ADHD but there is no association or interaction with SOB for increased risk for ADHD. Our findings suggest that we can refute a possible effect of SOB for ADHD. © 2007 Wiley-Liss, Inc.</description>
    <dc:title>Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth</dc:title>

    <dc:creator>KJ Brookes</dc:creator>
    <dc:creator>B Neale</dc:creator>
    <dc:creator>X Xu</dc:creator>
    <dc:creator>A Thapar</dc:creator>
    <dc:creator>M Gill</dc:creator>
    <dc:creator>K Langley</dc:creator>
    <dc:creator>Z Hawi</dc:creator>
    <dc:creator>J Mill</dc:creator>
    <dc:creator>E Taylor</dc:creator>
    <dc:creator>B Franke</dc:creator>
    <dc:creator>W Chen</dc:creator>
    <dc:creator>R Ebstein</dc:creator>
    <dc:creator>J Buitelaar</dc:creator>
    <dc:creator>T Banaschewski</dc:creator>
    <dc:creator>E Sonuga-Barke</dc:creator>
    <dc:creator>J Eisenberg</dc:creator>
    <dc:creator>Manor</dc:creator>
    <dc:creator>A Miranda</dc:creator>
    <dc:creator>RD Oades</dc:creator>
    <dc:creator>H Roeyers</dc:creator>
    <dc:creator>A Rothenberger</dc:creator>
    <dc:creator>J Sergeant</dc:creator>
    <dc:creator>HC Steinhausen</dc:creator>
    <dc:creator>SV Faraone</dc:creator>
    <dc:creator>P Asherson</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30562</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 1. (2008), pp. 94-99.</dc:source>
    <dc:date>2007-12-21T19:01:50-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</prism:publicationName>
    <prism:volume>147B</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>94</prism:startingPage>
    <prism:endingPage>99</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>association-study</prism:category>
    <prism:category>drd4</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>season-of-birth</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shupsy/article/2156594">
    <title>Family-based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals</title>
    <link>http://www.citeulike.org/user/shupsy/article/2156594</link>
    <description>&lt;i&gt;American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 1. (2008), pp. 100-106.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The objective of this study was to determine whether single nucleotide polymorphisms (SNPs) within candidate genes for ADHD are associated with quantitative phenotypes generated from inattentive and hyperactive-impulsive symptoms. One hundred forty-three SNPs were genotyped in and around five ADHD candidate genes. A highly heritable quantitative phenotype was generated at each SNP by weighting inattentive and hyperactive-impulsive symptoms. Once these phenotypes were generated, a screening procedure was used to select and test the five SNP/phenotype combinations with the greatest power to detect an association for each candidate gene. Adjacent SNPs in the promoter region of DRD4, hCV26775267 and hCV26775266, were associated with the quantitative phenotypes generated from the ADHD symptoms (corrected P-values = 0.012 for both SNPs). The correlations between the ADHD symptoms and quantitative phenotype revealed that inattentive symptoms had a strong influence on the generated phenotype. Subsequent family-based association test-principal components (FBAT-PC) analyses using inattentive symptoms only also had significant associations. SNPs in the promoter region of DRD4 are associated with the phenotypes generated from ADHD symptoms. The strong correlation of the inattentive symptoms with these quantitative phenotypes and the subsequent FBAT-PC analyses suggest this region is primarily associated with inattentive symptoms. This analysis adds to previous findings by suggesting that variants at these loci may be specifically associated with inattentive symptoms. © 2007 Wiley-Liss, Inc.</description>
    <dc:title>Family-based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals</dc:title>

    <dc:creator>J Lasky-Su</dc:creator>
    <dc:creator>C Lange</dc:creator>
    <dc:creator>J Biederman</dc:creator>
    <dc:creator>M Tsuang</dc:creator>
    <dc:creator>AE Doyle</dc:creator>
    <dc:creator>JW Smoller</dc:creator>
    <dc:creator>N Laird</dc:creator>
    <dc:creator>S Faraone</dc:creator>
    <dc:identifier>doi:10.1002/ajmg.b.30567</dc:identifier>
    <dc:source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 147B, No. 1. (2008), pp. 100-106.</dc:source>
    <dc:date>2007-12-21T18:59:10-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</prism:publicationName>
    <prism:volume>147B</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>100</prism:startingPage>
    <prism:endingPage>106</prism:endingPage>
    <prism:category>adhd</prism:category>
    <prism:category>drd4</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>inattention</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/shigepong/article/1086640">
    <title>Large scale genotype-phenotype correlation analysis based on phylogenetic trees.</title>
    <link>http://www.citeulike.org/user/shigepong/article/1086640</link>
    <description>&lt;i&gt;Bioinformatics (31 January 2007)&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;We provide two methods for identifying changes in genotype that are correlated with changes in a phenotype implied by phylogenetic trees. The first method, VENN, works when the number of branches over which the change occurred are modest. VENN looks for genetic changes that are completely penetrant with phenotype changes on a tree. The second method, CCTSWEEP, allows for a partial matching between changes in phenotypes and genotypes and provides a score for each change using Maddison's Concentrated Changes Test. The mutations that are highly correlated with phenotypic change can be ranked by score. We use these methods to find SNPs correlated with resistance to Bacillus anthracis in inbred mouse strains. Our findings are consistent with the current biological literature, and also suggest potential novel candidate genes.</description>
    <dc:title>Large scale genotype-phenotype correlation analysis based on phylogenetic trees.</dc:title>

    <dc:creator>Farhat Habib</dc:creator>
    <dc:creator>Andrew D Johnson</dc:creator>
    <dc:creator>Ralf Bundschuh</dc:creator>
    <dc:creator>Daniel Janies</dc:creator>
    <dc:identifier>doi:10.1093/bioinformatics/btm003</dc:identifier>
    <dc:source>Bioinformatics (31 January 2007)</dc:source>
    <dc:date>2007-02-04T07:45:09-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Bioinformatics</prism:publicationName>
    <prism:issn>1460-2059</prism:issn>
    <prism:category>genotype</prism:category>
    <prism:category>phenotype</prism:category>
    <prism:category>tree</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/Schmidtc/article/2430828">
    <title>A comprehensive molecular phylogeny of the starlings (Aves: Sturnidae) and mockingbirds (Aves: Mimidae): congruent mtDNA and nuclear trees for a cosmopolitan avian radiation.</title>
    <link>http://www.citeulike.org/user/Schmidtc/article/2430828</link>
    <description>&lt;i&gt;Mol Phylogenet Evol, Vol. 44, No. 3. (September 2007), pp. 1031-1056.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;We generated a comprehensive phylogeny for the avian families Sturnidae (starlings, mynas, Rhabdornis, oxpeckers, and allies) and Mimidae (mockingbirds, thrashers, and allies) to explore patterns of morphological and behavioral diversification. Reconstructions were based on mitochondrial DNA sequences from five coding genes (4108 bp), and nuclear intron sequences from four loci (2974 bp), for most taxa, supplemented with NDII gene sequences (1041 bp) derived from museum skin specimens from additional taxa; together the 117 sampled taxa comprise 78% of the 151 species in these families and include representatives of all currently or recently recognized genera. Phylogenetic analyses consistently identified nine major clades. The basal lineage is comprised of the two Buphagus oxpeckers, which are presently confined to Africa where they are obligately associated with large mammals. Some species in nearly all of the other major clades also feed on or around large vertebrates, and this association may be an ancestral trait that fostered the world-wide dispersal of this group. The remaining taxa divide into sister clades representing the New-World Mimidae and Old-World Sturnidae. The Mimidae are divided into two subclades, a group of Central American and West Indian catbirds and thrashers, and a pan-American clade of mockingbirds and thrashers. The Sturnidae are subdivided into six clades. The Phillipine endemic Rhabdornis are the sister lineage to a larger and substantially more recent radiation of South Asian and Pacific island starlings and mynas. A clade of largely migratory or nomadic Eurasian starlings (within which the basal lineage is the model taxon Sturnus vulgaris) is allied to three groups of largely African species. These reconstructions confirm that Buphagus should not be included in the Sturnidae, and identify many genera that are not monophyletic. They also highlight the substantial diversity among the major Sturnidae subclades in rates of species accumulation, morphological differentiation, and behavioral variation.</description>
    <dc:title>A comprehensive molecular phylogeny of the starlings (Aves: Sturnidae) and mockingbirds (Aves: Mimidae): congruent mtDNA and nuclear trees for a cosmopolitan avian radiation.</dc:title>

    <dc:creator>IJ Lovette</dc:creator>
    <dc:creator>DR Rubenstein</dc:creator>
    <dc:identifier>doi:10.1016/j.ympev.2007.03.017</dc:identifier>
    <dc:source>Mol Phylogenet Evol, Vol. 44, No. 3. (September 2007), pp. 1031-1056.</dc:source>
    <dc:date>2008-02-26T18:41:58-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Mol Phylogenet Evol</prism:publicationName>
    <prism:issn>1055-7903</prism:issn>
    <prism:volume>44</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>1031</prism:startingPage>
    <prism:endingPage>1056</prism:endingPage>
    <prism:category>catbird</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/Schmidtc/article/1628218">
    <title>Polymorphism at trinucleotide microsatellite loci in the subterranean termite Reticulitermes flavipes.</title>
    <link>http://www.citeulike.org/user/Schmidtc/article/1628218</link>
    <description>&lt;i&gt;Mol Ecol, Vol. 9, No. 6. (June 2000), pp. 817-820.&lt;/i&gt;</description>
    <dc:title>Polymorphism at trinucleotide microsatellite loci in the subterranean termite Reticulitermes flavipes.</dc:title>

    <dc:creator>EL Vargo</dc:creator>
    <dc:source>Mol Ecol, Vol. 9, No. 6. (June 2000), pp. 817-820.</dc:source>
    <dc:date>2007-09-06T18:33:39-00:00</dc:date>
    <prism:publicationYear>2000</prism:publicationYear>
    <prism:publicationName>Mol Ecol</prism:publicationName>
    <prism:issn>0962-1083</prism:issn>
    <prism:volume>9</prism:volume>
    <prism:number>6</prism:number>
    <prism:startingPage>817</prism:startingPage>
    <prism:endingPage>820</prism:endingPage>
    <prism:category>evolution</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>termites</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/Schmidtc/article/1628216">
    <title>Hierarchical analysis of colony and population genetic structure of the eastern subterranean termite, Reticulitermes flavipes, using two classes of molecular markers.</title>
    <link>http://www.citeulike.org/user/Schmidtc/article/1628216</link>
    <description>&lt;i&gt;Evolution Int J Org Evolution, Vol. 57, No. 12. (December 2003), pp. 2805-2818.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Termites (Isoptera) comprise a large and important group of eusocial insects, yet, in contrast to the eusocial Hymenoptera (ants, bees, wasps), the breeding systems of termites remain poorly understood. In this study, I inferred the breeding system of the subterranean termite Reticulitermes flavipes based on colony and population genetic structure as determined from microsatellite and mitochondrial DNA markers. Termites were sampled from natural wood debris from three undisturbed, forested sites in central North Carolina. In each site, two transects separated by 1 km were sampled at approximately 15-m intervals. A total of 1272 workers collected from 57 collection points were genotyped at six microsatellite loci, and mitochondrial DNA haplotype was determined for a subset of these individuals using either restriction fragment length polymorphism or sequence variation in the AT-rich region. Colonies appeared to be localized: workers from the 57 collection points represented 56 genetically distinct colonies with only a single colony occupying two collection points located 15 m apart. Genetic analysis of family structure and comparisons of estimates of F-statistics (F(IT), F(IC), F(CT)) and coefficients of relatedness (r) among nestmate workers with results of computer simulations of potential breeding systems suggested that 77% of all colonies were simple families headed by outbred monogamous pairs, whereas the remaining colonies were extended (inbred) families headed by low numbers of neotenics (about two females and one male) who were the direct offspring of the colony founders. There was no detectable isolation by distance among colonies along transects, suggesting that colony reproduction by budding is not common and that dispersal of reproductives during mating flights is not limited over this distance. Higher-level analysis of the microsatellite loci indicated weak but significant differentiation among sites (F(ST) = 0.06), a distance of 16-38 km, and between transects within sites (F(ST) = 0.06), a distance of 1 km. No significant differentiation at either the transect or site level was detected in the mitochondrial DNA sequence data. These results indicate that the study populations of R. flavipes have a breeding system characterized by monogamous pairs of outbred reproductives and relatively low levels of inbreeding because most colonies do not live long enough to produce neotenics, and those colonies that do generate neotenics contain an effectively small number of them.</description>
    <dc:title>Hierarchical analysis of colony and population genetic structure of the eastern subterranean termite, Reticulitermes flavipes, using two classes of molecular markers.</dc:title>

    <dc:creator>EL Vargo</dc:creator>
    <dc:source>Evolution Int J Org Evolution, Vol. 57, No. 12. (December 2003), pp. 2805-2818.</dc:source>
    <dc:date>2007-09-06T18:32:56-00:00</dc:date>
    <prism:publicationYear>2003</prism:publicationYear>
    <prism:publicationName>Evolution Int J Org Evolution</prism:publicationName>
    <prism:issn>0014-3820</prism:issn>
    <prism:volume>57</prism:volume>
    <prism:number>12</prism:number>
    <prism:startingPage>2805</prism:startingPage>
    <prism:endingPage>2818</prism:endingPage>
    <prism:category>evolution</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>termites</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/PeterDAdamo/article/771363">
    <title>Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.</title>
    <link>http://www.citeulike.org/user/PeterDAdamo/article/771363</link>
    <description>&lt;i&gt;Am J Clin Nutr, Vol. 82, No. 6. (December 2005)&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;BACKGROUND: Dietary isoflavones are thought to be cardioprotective because of their structural similarity to estrogen. The reduction of concentrations of circulating inflammatory markers by estrogen may be one of the mechanisms by which premenopausal women are protected against cardiovascular disease. OBJECTIVE: Our aim was to investigate the effects of isolated soy isoflavones on inflammatory biomarkers [von Willebrand factor, intracellular adhesion molecule 1, vascular cell adhesion molecule 1 (VCAM-1), E-selectin, monocyte chemoattractant protein 1, C-reactive protein (CRP), and endothelin 1 concentrations]. Differences with respect to single-nucleotide polymorphisms in selected genes [estrogen receptor alpha (XbaI and PvuII), estrogen receptor beta [ERbeta (AluI) and ERbeta[cx] (Tsp509I), endothelial nitric oxide synthase (Glu298Asp), apolipoprotein E (Apo E2, E3, and E4), and cholesteryl ester transfer protein (TaqIB)] and equol production were investigated. DESIGN: One hundred seventeen healthy European postmenopausal women participated in this randomized, double-blind, placebo-controlled, crossover dietary intervention trial. Isoflavone-enriched (genistein-to-daidzein ratio of 2:1; 50 mg/d) or placebo cereal bars were consumed for 8 wk, with a washout period of 8 wk between the crossover. Plasma inflammatory factors were measured at 0 and 8 wk of each study arm. RESULTS: Isoflavones improved CRP concentrations [odds ratio (95% CI) for CRP values &#62;1 mg/L for isoflavone compared with placebo: 0.43 (0.27, 0.69)]; no significant effects of isoflavone treatment on other plasma inflammatory markers were observed. No significant differences in the response to isoflavones were observed according to subgroups of equol production. Differences in the VCAM-1 response to isoflavones and to placebo were found with ERbeta AluI genotypes. CONCLUSION: Isoflavones have beneficial effects on CRP concentrations, but not on other inflammatory biomarkers of cardiovascular disease risk in postmenopausal women, and may improve VCAM-1 in an ERbeta gene polymorphic subgroup.</description>
    <dc:title>Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.</dc:title>

    <dc:creator>WL Hall</dc:creator>
    <dc:creator>K Vafeiadou</dc:creator>
    <dc:creator>J Hallund</dc:creator>
    <dc:creator>S Bügel</dc:creator>
    <dc:creator>C Koebnick</dc:creator>
    <dc:creator>M Reimann</dc:creator>
    <dc:creator>M Ferrari</dc:creator>
    <dc:creator>F Branca</dc:creator>
    <dc:creator>D Talbot</dc:creator>
    <dc:creator>T Dadd</dc:creator>
    <dc:creator>M Nilsson</dc:creator>
    <dc:creator>K Dahlman-Wright</dc:creator>
    <dc:creator>JA Gustafsson</dc:creator>
    <dc:creator>AM Minihane</dc:creator>
    <dc:creator>CM Williams</dc:creator>
    <dc:source>Am J Clin Nutr, Vol. 82, No. 6. (December 2005)</dc:source>
    <dc:date>2006-07-24T14:33:21-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Am J Clin Nutr</prism:publicationName>
    <prism:issn>0002-9165</prism:issn>
    <prism:volume>82</prism:volume>
    <prism:number>6</prism:number>
    <prism:category>equol</prism:category>
    <prism:category>flavone</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>soy</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/PeterDAdamo/article/771286">
    <title>Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women.</title>
    <link>http://www.citeulike.org/user/PeterDAdamo/article/771286</link>
    <description>&lt;i&gt;Proc Nutr Soc, Vol. 65, No. 1. (February 2006), pp. 106-115.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The increase in CVD incidence following the menopause is associated with oestrogen loss. Dietary isoflavones are thought to be cardioprotective via their oestrogenic and oestrogen receptor-independent effects, but evidence to support this role is scarce. Individual variation in response to diet may be considerable and can obscure potential beneficial effects in a sample population; in particular, the response to isoflavone treatment may vary according to genotype and equol-production status. The effects of isoflavone supplementation (50 mg/d) on a range of established and novel biomarkers of CVD, including markers of lipid and glucose metabolism and inflammatory biomarkers, have been investigated in a placebo-controlled 2 x 8-week randomised cross-over study in 117 healthy post-menopausal women. Responsiveness to isoflavone supplementation according to (1) single nucleotide polymorphisms in a range of key CVD genes, including oestrogen receptor (ER) alpha and beta and (2) equol-production status has been examined. Isoflavones supplementation was found to have no effect on markers of lipids and glucose metabolism. Isoflavones improve C-reactive protein concentrations but do not affect other plasma inflammatory markers. There are no differences in response to isoflavones according to equol-production status. However, differences in HDL-cholesterol and vascular cell adhesion molecule 1 response to isoflavones v. placebo are evident with specific ERbeta genotypes. In conclusion, isoflavones have beneficial effects on C-reactive protein, but not other cardiovascular risk markers. However, specific ERbeta gene polymorphic subgroups may benefit from isoflavone supplementation.</description>
    <dc:title>Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women.</dc:title>

    <dc:creator>K Vafeiadou</dc:creator>
    <dc:creator>WL Hall</dc:creator>
    <dc:creator>CM Williams</dc:creator>
    <dc:source>Proc Nutr Soc, Vol. 65, No. 1. (February 2006), pp. 106-115.</dc:source>
    <dc:date>2006-07-24T14:32:42-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>Proc Nutr Soc</prism:publicationName>
    <prism:issn>0029-6651</prism:issn>
    <prism:volume>65</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>106</prism:startingPage>
    <prism:endingPage>115</prism:endingPage>
    <prism:category>equol</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>soy</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/PeterDAdamo/article/749641">
    <title>Evolution in Four Dimensions : Genetic, Epigenetic, Behavioral, and Symbolic Variation in the History of Life</title>
    <link>http://www.citeulike.org/user/PeterDAdamo/article/749641</link>
    <description>&lt;i&gt;(01 October 2006)&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Ideas about heredity and evolution are undergoing a revolutionary change. New findings in molecular biology challenge the gene-centered version of Darwinian theory according to which adaptation occurs only through natural selection of chance DNA variations. In &#60;i&#62;Evolution in Four Dimensions&#60;/i&#62;, Eva Jablonka and Marion Lamb argue that there is more to heredity than genes. They trace four &#34;dimensions&#34; in evolution -- four inheritance systems that play a role in evolution: genetic, epigenetic (or non-DNA cellular transmission of traits), behavioral, and symbolic (transmission through language and other forms of symbolic communication). These systems, they argue, can all provide variations on which natural selection can act. &#60;i&#62;Evolution in Four Dimensions&#60;/i&#62; offers a richer, more complex view of evolution than the gene-based, one-dimensional view held by many today. The new synthesis advanced by Jablonka and Lamb makes clear that induced and acquired changes also play a role in evolution.&#60;br /&#62; &#60;br /&#62; After discussing each of the four inheritance systems in detail, Jablonka and Lamb &#34;put Humpty Dumpty together again&#34; by showing how all of these systems interact. They consider how each may have originated and guided evolutionary history and they discuss the social and philosophical implications of the four-dimensional view of evolution. Each chapter ends with a dialogue in which the authors engage the contrarieties of the fictional (and skeptical) &#34;I.M.,&#34; or Ifcha Mistabra -- Aramaic for &#34;the opposite conjecture&#34; -- refining their arguments against I.M.'s vigorous counterarguments. The lucid and accessible text is accompanied by artist-physician Anna Zeligowski's lively drawings, which humorously and effectively illustrate the authors' points.</description>
    <dc:title>Evolution in Four Dimensions : Genetic, Epigenetic, Behavioral, and Symbolic Variation in the History of Life</dc:title>

    <dc:creator>Eva Jablonka</dc:creator>
    <dc:creator>Marion Lamb</dc:creator>
    <dc:source>(01 October 2006)</dc:source>
    <dc:date>2006-07-10T19:50:10-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publisher>The MIT Press</prism:publisher>
    <prism:category>epigenetics</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/okarsligil/article/525519">
    <title>Ab initio genotype-phenotype association reveals intrinsic modularity in genetic networks</title>
    <link>http://www.citeulike.org/user/okarsligil/article/525519</link>
    <description>&lt;i&gt;Mol Syst Biol, Vol. 2, No. 1. (31 January 2006), pp. msb4100047-E1-msb4100047-E14.&lt;/i&gt;</description>
    <dc:title>Ab initio genotype-phenotype association reveals intrinsic modularity in genetic networks</dc:title>

    <dc:creator>Noam Slonim</dc:creator>
    <dc:creator>Olivier Elemento</dc:creator>
    <dc:creator>Saeed Tavazoie</dc:creator>
    <dc:identifier>doi:10.1038/msb4100047</dc:identifier>
    <dc:source>Mol Syst Biol, Vol. 2, No. 1. (31 January 2006), pp. msb4100047-E1-msb4100047-E14.</dc:source>
    <dc:date>2006-03-01T17:03:09-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>Mol Syst Biol</prism:publicationName>
    <prism:volume>2</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>msb4100047-E1</prism:startingPage>
    <prism:endingPage>msb4100047-E14</prism:endingPage>
    <prism:category>genotype</prism:category>
    <prism:category>network</prism:category>
    <prism:category>phenotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1306019">
    <title>Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity.</title>
    <link>http://www.citeulike.org/user/oamg/article/1306019</link>
    <description>&lt;i&gt;Psychopharmacology (Berl), Vol. 182, No. 4. (November 2005), pp. 570-578.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;RATIONALE: Reduced serotonin neurotransmission is implicated in disorders of impulse control, but the involvement of serotonin in inhibitory processes in healthy human subjects remains unclear. OBJECTIVES: To investigate the effects of an acute manipulation of serotonin and genotype at a functional polymorphism in a gene coding for the serotonin transporter (5-HTT) on an established measure of response inhibition. METHODS: Serotonin function was reduced by the acute tryptophan depletion (ATD) procedure in a double-blind, crossover design in 42 healthy subjects. The Stop Signal Task (SST) was administered 5-7 h after drink administration. The influences of 5-HTT polymorphism, gender and trait impulsivity were investigated. RESULTS: ATD was associated with significant depletion of plasma tryptophan levels but did not increase the stop signal reaction time in comparison to the balanced (placebo) amino acid mixture. Subjects possessing the short allele of the 5-HTT polymorphism were not more impulsive on the SST than subjects homozygous for the long allele under placebo conditions and were not disproportionately sensitive to the effects of ATD. There was no effect of gender or trait impulsivity on ATD-induced change. CONCLUSIONS: We find no support for the involvement of brain serotonin neurotransmission in this form of inhibitory control in healthy human subjects.</description>
    <dc:title>Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity.</dc:title>

    <dc:creator>L Clark</dc:creator>
    <dc:creator>JP Roiser</dc:creator>
    <dc:creator>R Cools</dc:creator>
    <dc:creator>DC Rubinsztein</dc:creator>
    <dc:creator>BJ Sahakian</dc:creator>
    <dc:creator>TW Robbins</dc:creator>
    <dc:identifier>doi:10.1007/s00213-005-0104-6</dc:identifier>
    <dc:source>Psychopharmacology (Berl), Vol. 182, No. 4. (November 2005), pp. 570-578.</dc:source>
    <dc:date>2007-05-18T17:06:21-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Psychopharmacology (Berl)</prism:publicationName>
    <prism:issn>0033-3158</prism:issn>
    <prism:volume>182</prism:volume>
    <prism:number>4</prism:number>
    <prism:startingPage>570</prism:startingPage>
    <prism:endingPage>578</prism:endingPage>
    <prism:category>5-ht_theory_of_impulsivity</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>serotonin</prism:category>
    <prism:category>tryptophan_depletion</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1137915">
    <title>Warriors versus worriers: the role of COMT gene variants.</title>
    <link>http://www.citeulike.org/user/oamg/article/1137915</link>
    <description>&lt;i&gt;CNS Spectr, Vol. 11, No. 10. (October 2006), pp. 745-748.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Behavioral phenotypes are generally complex, reflecting the action of multiple different genes. Nevertheless, there is growing evidence that key gene variants can alter activity within specific neuronal circuits and, therefore, influence particular cognitive-affective phenomena. One example is the catechol-O-methyltransferase (COMT) gene, which has a common variant at codon 158. Those with valine (Val158) alleles have increased greater COMT activity and lower prefrontal extracellular dopamine compared with those with the methionine (Met158) substitution. Val158 alleles may be associated with an advantage in the processing of aversive stimuli (warrior strategy), while Met158 alleles may be associated with an advantage in memory and attention tasks (worrier strategy). Under conditions of increased dopamine release (eg, stress), individuals with Val158 alleles may have improved dopaminergic transmission and better performance, while individuals with Met158 alleles may have less efficient neurotransmission and worse performance. Some evidence suggests that Val158 alleles are associated with schizophrenia, while Met158 alleles are associated with anxiety.</description>
    <dc:title>Warriors versus worriers: the role of COMT gene variants.</dc:title>

    <dc:creator>DJ Stein</dc:creator>
    <dc:creator>TK Newman</dc:creator>
    <dc:creator>J Savitz</dc:creator>
    <dc:creator>R Ramesar</dc:creator>
    <dc:source>CNS Spectr, Vol. 11, No. 10. (October 2006), pp. 745-748.</dc:source>
    <dc:date>2007-03-03T16:32:47-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>CNS Spectr</prism:publicationName>
    <prism:issn>1092-8529</prism:issn>
    <prism:volume>11</prism:volume>
    <prism:number>10</prism:number>
    <prism:startingPage>745</prism:startingPage>
    <prism:endingPage>748</prism:endingPage>
    <prism:category>dopamine</prism:category>
    <prism:category>gene</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1300401">
    <title>Impaired Executive Control Is Associated with a Variation in the Promoter Region of the Tryptophan Hydroxylase 2 Gene</title>
    <link>http://www.citeulike.org/user/oamg/article/1300401</link>
    <description>&lt;i&gt;J. Cogn. Neurosci., Vol. 19, No. 3. (1 March 2007), pp. 401-408.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Current models of attention describe attention not as a homogenous entity but as a set of neural networks whose measurement yields a set of three endophenotypes--alerting, orienting, and executive control. Previous findings revealed different neuroanatomical regions for these subsystems, and data from twin studies indicate differences in their heritability. The present study investigated the molecular genetic basis of attention in a sample of 100 healthy subjects. Attention performance was assessed with the attention network test that distinguishes alerting, orienting, and executive control (conflict) using a simple reaction time paradigm with different cues and congruent and incongruent flankers. Two gene loci on candidate genes for cognitive functioning, the functional catechol-O-methyltransferase (COMT) VAL158MET and the tryptophan hydroxylase 2 (TPH2) -703 G/T promoter polymorphism, were tested for possible associations with attention. COMT is involved in the catabolism of dopamine, and TPH is the rate-limiting enzyme for serotonin synthesis. Results showed no effect of the COMT polymorphism on attention performance. However, the TT genotype of TPH2 -703 G/T was significantly associated with more errors (a possible indicator of impaired impulse control; p = .001) and with decreased performance in executive control (p = .001). This single-nucleotide polymorphism on the TPH2 gene explained more than 10% of the variance in both indicators of attention stressing the role of the serotonergic system for cognitive functions.</description>
    <dc:title>Impaired Executive Control Is Associated with a Variation in the Promoter Region of the Tryptophan Hydroxylase 2 Gene</dc:title>

    <dc:creator>Martin Reuter</dc:creator>
    <dc:creator>Ulrich Ott</dc:creator>
    <dc:creator>Dieter Vaitl</dc:creator>
    <dc:creator>Jurgen Hennig</dc:creator>
    <dc:source>J. Cogn. Neurosci., Vol. 19, No. 3. (1 March 2007), pp. 401-408.</dc:source>
    <dc:date>2007-05-16T15:38:33-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>J. Cogn. Neurosci.</prism:publicationName>
    <prism:volume>19</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>401</prism:startingPage>
    <prism:endingPage>408</prism:endingPage>
    <prism:category>executive_control</prism:category>
    <prism:category>gene</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>tryptophan</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1401455">
    <title>Neural mechanisms of aggression</title>
    <link>http://www.citeulike.org/user/oamg/article/1401455</link>
    <description>&lt;i&gt;Nat Rev Neurosci, Vol. 8, No. 7. (July 2007), pp. 536-546.&lt;/i&gt;</description>
    <dc:title>Neural mechanisms of aggression</dc:title>

    <dc:creator>Randy Nelson</dc:creator>
    <dc:creator>Brian Trainor</dc:creator>
    <dc:identifier>doi:10.1038/nrn2174</dc:identifier>
    <dc:source>Nat Rev Neurosci, Vol. 8, No. 7. (July 2007), pp. 536-546.</dc:source>
    <dc:date>2007-06-20T17:30:22-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Nat Rev Neurosci</prism:publicationName>
    <prism:volume>8</prism:volume>
    <prism:number>7</prism:number>
    <prism:startingPage>536</prism:startingPage>
    <prism:endingPage>546</prism:endingPage>
    <prism:category>aggression</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>nature_nurture</prism:category>
    <prism:category>review</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1325483">
    <title>Hippocampal spatial memory impairments caused by the familial Alzheimer's disease-linked presenilin 1 M146V mutation.</title>
    <link>http://www.citeulike.org/user/oamg/article/1325483</link>
    <description>&lt;i&gt;Neurodegener Dis, Vol. 2, No. 1. (2005), pp. 6-15.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Mutations in presenilins (PS) 1 and 2 are the major cause of familial Alzheimer's disease. Conditional inactivation of PS1 in the mouse postnatal forebrain leads to mild deficits in spatial learning and memory, whereas inactivation of both PS1 and PS2 results in severe memory and synaptic plasticity impairments, followed by progressive and substantial neurodegeneration. Here we investigate the effect of a familial Alzheimer's disease-linked PS1 missense mutation using knock-in (KI) mice, in which the wild-type PS1 allele is replaced with the M146V mutant allele. In the Morris water maze task, PS1 KI mice at 3 months of age exhibit reduced quadrant occupancy and platform crossing in the probe trial after 6 days of training, though their performance was normal in the probe trial after 12 days of training. By the age of 9 months, even after 12 days of training, PS1 homozygous KI mice still exhibit reduced platform crossing in the post-training probe trial. ELISA analysis revealed a selective increase in cortical levels of beta-amyloid 42 in PS1 KI mice, whereas production of beta-amyloid 40 was normal. Histological and quantitative real-time RT-PCR analyses showed normal gross hippocampal morphology and unaltered expression of three genes involved in inflammatory responses in PS1 KI mice. These results show hippocampal spatial memory impairments caused by the PS1 M146V mutation and age-related deterioration of the memory impairment, suggesting that PS1 KI mice are a valuable model system for the study of memory loss in AD.</description>
    <dc:title>Hippocampal spatial memory impairments caused by the familial Alzheimer's disease-linked presenilin 1 M146V mutation.</dc:title>

    <dc:creator>X Sun</dc:creator>
    <dc:creator>V Beglopoulos</dc:creator>
    <dc:creator>MP Mattson</dc:creator>
    <dc:creator>J Shen</dc:creator>
    <dc:identifier>doi:10.1159/000086426</dc:identifier>
    <dc:source>Neurodegener Dis, Vol. 2, No. 1. (2005), pp. 6-15.</dc:source>
    <dc:date>2007-05-24T17:15:18-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Neurodegener Dis</prism:publicationName>
    <prism:issn>1660-2854</prism:issn>
    <prism:volume>2</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>6</prism:startingPage>
    <prism:endingPage>15</prism:endingPage>
    <prism:category>genotype</prism:category>
    <prism:category>hippocampal</prism:category>
    <prism:category>m146v</prism:category>
    <prism:category>spatial_memory</prism:category>
    <prism:category>spatial_processing</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1240020">
    <title>Individual differences in extraversion and dopamine genetics predict neural reward responses.</title>
    <link>http://www.citeulike.org/user/oamg/article/1240020</link>
    <description>&lt;i&gt;Brain Res Cogn Brain Res, Vol. 25, No. 3. (December 2005), pp. 851-861.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Psychologists have linked the personality trait extraversion both to differences in reward sensitivity and to dopamine functioning, but little is known about how these differences are reflected in the functioning of the brain's dopaminergic neural reward system. Here, we show that individual differences in extraversion and the presence of the A1 allele on the dopamine D2 receptor gene predict activation magnitudes in the brain's reward system during a gambling task. In two functional MRI experiments, participants probabilistically received rewards either immediately following a behavioral response (Study 1) or after a 7.5 s anticipation period (Study 2). Although group activation maps revealed anticipation- and reward-related activations in the reward system, individual differences in extraversion and the presence of the D2 Taq1A allele predicted a significant amount of inter-subject variability in the magnitudes of reward-related, but not anticipation-related, activations. These results demonstrate a link between stable differences in personality, genetics, and brain functioning.</description>
    <dc:title>Individual differences in extraversion and dopamine genetics predict neural reward responses.</dc:title>

    <dc:creator>MX Cohen</dc:creator>
    <dc:creator>J Young</dc:creator>
    <dc:creator>JM Baek</dc:creator>
    <dc:creator>C Kessler</dc:creator>
    <dc:creator>C Ranganath</dc:creator>
    <dc:identifier>doi:10.1016/j.cogbrainres.2005.09.018</dc:identifier>
    <dc:source>Brain Res Cogn Brain Res, Vol. 25, No. 3. (December 2005), pp. 851-861.</dc:source>
    <dc:date>2007-04-20T16:30:12-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Brain Res Cogn Brain Res</prism:publicationName>
    <prism:issn>0926-6410</prism:issn>
    <prism:volume>25</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>851</prism:startingPage>
    <prism:endingPage>861</prism:endingPage>
    <prism:category>decision-making</prism:category>
    <prism:category>dopamine</prism:category>
    <prism:category>extraversion</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>reward</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1239993">
    <title>Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients.</title>
    <link>http://www.citeulike.org/user/oamg/article/1239993</link>
    <description>&lt;i&gt;Genes Brain Behav (26 March 2007)&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Gene polymorphisms in the mammalian biological clock system influence individual rhythms. A single nucleotide polymorphism (SNP) in the 3' flanking region of CLOCK (3111 T/C; rs1801260) influenced diurnal preference in healthy humans and caused sleep phase delay and insomnia in patients affected by bipolar disorder. Genes of the biological clock are expressed in many brain structures other than in the 'master clock' suprachiasmatic nuclei. These areas, such as cingulate cortex, are involved in the control of many human behaviors. Clock genes could then bias 'nonclock' functions such as information processing and decision making. Thirty inpatients affected by a major depressive episode underwent blood oxygen-level dependent (BOLD) functional magnetic resonance imaging (fMRI). The cognitive activation paradigm was based on a go/no-go task. Morally connoted words were presented. Genotyping of CLOCK was performed for each patients. We measured activity levels through actimetry during the day before the fMRI study. CLOCK 3111 T/C SNP was associated with activity levels in the second part of the day, neuropsychological performance and BOLD fMRI correlates (interaction of genotype and moral valence of the stimuli). Our results support the hypothesis that individual clock genotype may influence several variables linked with human behaviors in normal and psychopathological conditions.</description>
    <dc:title>Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients.</dc:title>

    <dc:creator>F Benedetti</dc:creator>
    <dc:creator>D Radaelli</dc:creator>
    <dc:creator>A Bernasconi</dc:creator>
    <dc:creator>S Dallaspezia</dc:creator>
    <dc:creator>A Falini</dc:creator>
    <dc:creator>G Scotti</dc:creator>
    <dc:creator>C Lorenzi</dc:creator>
    <dc:creator>C Colombo</dc:creator>
    <dc:creator>E Smeraldi</dc:creator>
    <dc:identifier>doi:10.1111/j.1601-183X.2007.00312.x</dc:identifier>
    <dc:source>Genes Brain Behav (26 March 2007)</dc:source>
    <dc:date>2007-04-20T16:20:33-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Genes Brain Behav</prism:publicationName>
    <prism:issn>1601-1848</prism:issn>
    <prism:category>clock</prism:category>
    <prism:category>genotype</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/550595">
    <title>The molecular genetic architecture of human personality: beyond self-report questionnaires</title>
    <link>http://www.citeulike.org/user/oamg/article/550595</link>
    <description>&lt;i&gt;Molecular Psychiatry, Vol. aop, No. current.&lt;/i&gt;</description>
    <dc:title>The molecular genetic architecture of human personality: beyond self-report questionnaires</dc:title>

    <dc:creator>RP Ebstein</dc:creator>
    <dc:creator></dc:creator>
    <dc:identifier>doi:10.1038/sj.mp.4001814</dc:identifier>
    <dc:source>Molecular Psychiatry, Vol. aop, No. current.</dc:source>
    <dc:date>2006-03-14T11:12:19-00:00</dc:date>
    <prism:publicationName>Molecular Psychiatry</prism:publicationName>
    <prism:issn>1359-4184</prism:issn>
    <prism:volume>aop</prism:volume>
    <prism:number>current</prism:number>
    <prism:publisher>Nature Publishing Group</prism:publisher>
    <prism:category>dopamine</prism:category>
    <prism:category>drd4</prism:category>
    <prism:category>genotype</prism:category>
    <prism:category>human</prism:category>
    <prism:category>personality</prism:category>
    <prism:category>self-report</prism:category>
    <prism:category>serotonin</prism:category>
    <prism:category>slc6a4</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1273817">
    <title>Machine learning approaches for phenotype-genotype mapping: predicting heterozygous mutations in the CYP21B gene from steroid profiles.</title>
    <link>http://www.citeulike.org/user/oamg/article/1273817</link>
    <description>&lt;i&gt;Eur J Endocrinol, Vol. 153, No. 2. (August 2005), pp. 301-305.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;OBJECTIVE: Non-linear relations between multiple biochemical parameters are the basis for the diagnosis of many diseases. Traditional linear analytical methods are not reliable predictors. Novel nonlinear techniques are increasingly used to improve the diagnostic accuracy of automated data interpretation. This has been exemplified in particular for the classification and diagnostic prediction of cancers based on expression profiling data. Our objective was to predict the genotype from complex biochemical data by comparing the performance of experienced clinicians to traditional linear analysis, and to novel non-linear analytical methods. DESIGN AND METHODS: As a model, we used a well-defined set of interconnected data consisting of unstimulated serum levels of steroid intermediates assessed in 54 subjects heterozygous for a mutation of the 21-hydroxylase gene (CYP21B) and in 43 healthy controls. RESULTS: The genetic alteration was predicted from the pattern of steroid levels with an accuracy of 39% by clinicians and of 64% by linear analysis. In contrast, non-linear analysis, such as self-organizing artificial neural networks, support vector machines, and nearest neighbour classifiers, allowed for higher accuracy up to 83%. CONCLUSIONS: The successful application of these non-linear adaptive methods to capture specific biochemical problems may have generalized implications for biochemical testing in many areas. Nonlinear analytical techniques such as neural networks, support vector machines, and nearest neighbour classifiers may serve as an important adjunct to the decision process of a human investigator not 'trained' in a specific complex clinical or laboratory setting and may aid them to classify the problem more directly.</description>
    <dc:title>Machine learning approaches for phenotype-genotype mapping: predicting heterozygous mutations in the CYP21B gene from steroid profiles.</dc:title>

    <dc:creator>K Prank</dc:creator>
    <dc:creator>E Schulze</dc:creator>
    <dc:creator>O Eckert</dc:creator>
    <dc:creator>TW Nattkemper</dc:creator>
    <dc:creator>M Bettendorf</dc:creator>
    <dc:creator>C Maser-Gluth</dc:creator>
    <dc:creator>TJ Sejnowski</dc:creator>
    <dc:creator>A Grote</dc:creator>
    <dc:creator>E Penner</dc:creator>
    <dc:creator>A von Zur Mühlen</dc:creator>
    <dc:creator>G Brabant</dc:creator>
    <dc:identifier>doi:10.1530/eje.1.01957</dc:identifier>
    <dc:source>Eur J Endocrinol, Vol. 153, No. 2. (August 2005), pp. 301-305.</dc:source>
    <dc:date>2007-05-03T13:19:13-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Eur J Endocrinol</prism:publicationName>
    <prism:issn>0804-4643</prism:issn>
    <prism:volume>153</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>301</prism:startingPage>
    <prism:endingPage>305</prism:endingPage>
    <prism:category>genotype</prism:category>
    <prism:category>learning</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/oamg/article/1398887">
    <title>A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States.</title>
    <link>http://www.citeulike.org/user/oamg/article/1398887</link>
    <description>&lt;i&gt;Arch Gen Psychiatry, Vol. 59, No. 9. (September 2002), pp. 825-831.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;BACKGROUND: Quantitative trait locus studies, and observations in animals manipulated for the neuropeptide Y (NPY) gene suggest that variation within this gene may contribute to alcoholism. A recent population study suggested that the Pro7 allele of a functional NPY polymorphism (Leu7Pro) may be associated with increased alcohol consumption. We tested whether the Pro7 allele is associated with alcohol dependence in European Americans (EA). METHODS: The design was a population study comparing the Leu7Pro allele frequencies in alcohol-dependent subjects and controls. Population stratification potential and diagnostic specificity was studied by genotyping individuals from additional populations and psychiatric diagnostic classes. We studied 2 independently collected samples of EA alcohol-dependent subjects (sample 1, n = 307; sample 2, n = 160) and a sample of psychiatrically screened EA controls (n = 202); 8 population samples, including African Americans and European Americans (total n = 551); and 4 samples of individuals with Alzheimer disease, schizophrenia, posttraumatic stress disorder, and major depression (total n = 502). The main outcome measure was the difference in Leu7Pro allele frequencies between alcohol-dependent subjects and controls. RESULTS: The frequency of the Pro7 allele was higher in the alcohol-dependent subjects (sample 1, 5.5%; sample 2, 5.0%) compared with the screened EA controls (2.0%) (sample 1 vs controls, P=.006; sample 2 vs controls, P=.03). The attributable fraction (excess morbidity) in similarly affected populations, owing to the Pro7 allele, was estimated to be 7.3%. The frequency of the Pro7 allele was equal or lower in the population samples, as compared with the screened EA controls (0%-2.2%), with 1 exception (Bedouins). We found no significant evidence that the association of the Pro7 allele with alcohol dependence was due to an association with a comorbid psychiatric disorder. CONCLUSIONS: These results suggest that the NPY Pro7 allele is a risk factor for alcohol dependence. This is only the second specific genetic mechanism ever identified that modulates risk for alcohol dependence.</description>
    <dc:title>A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States.</dc:title>

    <dc:creator>J Lappalainen</dc:creator>
    <dc:creator>HR Kranzler</dc:creator>
    <dc:creator>R Malison</dc:creator>
    <dc:creator>LH Price</dc:creator>
    <dc:creator>C Van Dyck</dc:creator>
    <dc:creator>RA Rosenheck</dc:creator>
    <dc:creator>J Cramer</dc:creator>
    <dc:creator>S Southwick</dc:creator>
    <dc:creator>D Charney</dc:creator>
    <dc:creator>J Krystal</dc:creator>
    <dc:creator>J Gelernter</dc:creator>
    <dc:source>Arch Gen Psychiatry, Vol. 59, No. 9. (September 2002), pp. 8